<SEC-DOCUMENT>0001077183-23-000039.txt : 20230508
<SEC-HEADER>0001077183-23-000039.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508161042
ACCESSION NUMBER:		0001077183-23-000039
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230508
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEOGENOMICS INC
		CENTRAL INDEX KEY:			0001077183
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-TESTING LABORATORIES [8734]
		IRS NUMBER:				742897368
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35756
		FILM NUMBER:		23897833

	BUSINESS ADDRESS:	
		STREET 1:		9490 NEOGENOMICS WAY
		CITY:			FORT MYERS
		STATE:			FL
		ZIP:			33912
		BUSINESS PHONE:		2397680600

	MAIL ADDRESS:	
		STREET 1:		9490 NEOGENOMICS WAY
		CITY:			FORT MYERS
		STATE:			FL
		ZIP:			33912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMERICAN COMMUNICATIONS ENTERPRISES INC
		DATE OF NAME CHANGE:	19990120
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>neo-20230508.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:d3fe8359-94c4-4e01-8695-3cfc87e375dc,g:093795f1-7a86-4f35-b36e-e687fc3845d6,d:8cb52482a13e42e6992f084e5a739f03--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>neo-20230508</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM180L2ZyYWc6NDI0MTdiZjY3MzA4NDZjZGI4Zjk3ZjRjZTQ5NGY3ZTcvdGFibGU6OThkNDMwOGQ2ZWFiNDQxNjhiNTg5MzE1MzBjYmYzMjAvdGFibGVyYW5nZTo5OGQ0MzA4ZDZlYWI0NDE2OGI1ODkzMTUzMGNiZjMyMF8xLTEtMS0xLTE2NzU0OA_dcb5e5b1-b63c-4857-b7df-189640d21fae">0001077183</ix:nonNumeric><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM180L2ZyYWc6NDI0MTdiZjY3MzA4NDZjZGI4Zjk3ZjRjZTQ5NGY3ZTcvdGFibGU6OThkNDMwOGQ2ZWFiNDQxNjhiNTg5MzE1MzBjYmYzMjAvdGFibGVyYW5nZTo5OGQ0MzA4ZDZlYWI0NDE2OGI1ODkzMTUzMGNiZjMyMF8yLTEtMS0xLTE2NzU0OA_73c3e4e3-36cb-4ff4-b94f-dc0b209aa477">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="neo-20230508.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001077183</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-08</xbrli:startDate><xbrli:endDate>2023-05-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8cb52482a13e42e6992f084e5a739f03_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:242pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV84Mw_f48bbb60-1364-4a8e-a2bb-4e9e321e60d0">8-K</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yMjQ_b02090ba-16ff-432a-8a85-dd74fa47086d">May&#160;8, 2023</ix:nonNumeric></span></div><div style="text-align:center;text-indent:242pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:23pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yMjk_d088e705-865e-4760-a37c-0465a69ae00a">NEOGENOMICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.801%"><tr><td style="width:1.0%"></td><td style="width:40.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6NGU3OThkNDM4MDNkNDdjNjllZDFmZDM3NDAwNmNlNWMvdGFibGVyYW5nZTo0ZTc5OGQ0MzgwM2Q0N2M2OWVkMWZkMzc0MDA2Y2U1Y18wLTAtMS0xLTE2NzU0OC90ZXh0cmVnaW9uOmIxYjYyYzc3MzVkNDRjNmM5YjRiZGY5MjYzMTNhOWZjXzQ_de1971ac-bcbd-4a85-bec6-da7525658369">Nevada</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6NGU3OThkNDM4MDNkNDdjNjllZDFmZDM3NDAwNmNlNWMvdGFibGVyYW5nZTo0ZTc5OGQ0MzgwM2Q0N2M2OWVkMWZkMzc0MDA2Y2U1Y18wLTItMS0xLTE2NzU0OC90ZXh0cmVnaW9uOjE4ODZmMTExZjI2ODQ5OTQ5ZjZkYzBiNWU1ZDVmMGExXzQ_e98075e7-268d-44ea-a2f0-56f65e4fba1e">001-35756</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6NGU3OThkNDM4MDNkNDdjNjllZDFmZDM3NDAwNmNlNWMvdGFibGVyYW5nZTo0ZTc5OGQ0MzgwM2Q0N2M2OWVkMWZkMzc0MDA2Y2U1Y18wLTQtMS0xLTE2NzU0OC90ZXh0cmVnaW9uOjcxMTE2NGZiYTkxNTRhZTM4ZDRhZmY3NWRkYTFiZTA5XzQ_07a96693-e8df-49c1-a09e-61b2ff66eccd">74-2897368</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.929%"><tr><td style="width:1.0%"></td><td style="width:42.825%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.527%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6MGZmYTM2NDFhZGU0NDhjZDhiMDQ5YjY2MDA0MWVlZGMvdGFibGVyYW5nZTowZmZhMzY0MWFkZTQ0OGNkOGIwNDliNjYwMDQxZWVkY18wLTAtMS0xLTE2NzU0OA_57638ca6-94be-468c-8558-dd250b822136">9490 NeoGenomics Way,</ix:nonNumeric>   </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6MGZmYTM2NDFhZGU0NDhjZDhiMDQ5YjY2MDA0MWVlZGMvdGFibGVyYW5nZTowZmZhMzY0MWFkZTQ0OGNkOGIwNDliNjYwMDQxZWVkY18wLTEtMS0xLTE2NzU0OA_2a2df5ff-8e87-468c-82f4-8e025ace3445">Fort Myers,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6MGZmYTM2NDFhZGU0NDhjZDhiMDQ5YjY2MDA0MWVlZGMvdGFibGVyYW5nZTowZmZhMzY0MWFkZTQ0OGNkOGIwNDliNjYwMDQxZWVkY18wLTItMS0xLTE2NzU0OA_ae9142ea-de61-420f-951d-89a983225c51">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6MGZmYTM2NDFhZGU0NDhjZDhiMDQ5YjY2MDA0MWVlZGMvdGFibGVyYW5nZTowZmZhMzY0MWFkZTQ0OGNkOGIwNDliNjYwMDQxZWVkY18wLTMtMS0xLTE2NzU0OA_bb8bc631-0293-4ead-89f4-5f919e289de2">33912</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yOTQ_ed45af1b-671e-4c23-b420-3134dd22a7bb">(239)</ix:nonNumeric> <ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yOTc_1af9b3e0-30d6-473a-aa2d-01ba10452bf0">768-0600</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:242pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6OGNhNjRhOTNiYWUwNGRmODhjNDFiOTRkZjk3NWNhM2EvdGFibGVyYW5nZTo4Y2E2NGE5M2JhZTA0ZGY4OGM0MWI5NGRmOTc1Y2EzYV8wLTAtMS0xLTE2NzU0OA_3f57f4e0-5753-4c7f-9149-a37109f388b9">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6OGNhNjRhOTNiYWUwNGRmODhjNDFiOTRkZjk3NWNhM2EvdGFibGVyYW5nZTo4Y2E2NGE5M2JhZTA0ZGY4OGM0MWI5NGRmOTc1Y2EzYV8xLTAtMS0xLTE2NzU0OA_2d569a16-0ecf-4591-ada3-40f6dc09f5aa">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6OGNhNjRhOTNiYWUwNGRmODhjNDFiOTRkZjk3NWNhM2EvdGFibGVyYW5nZTo4Y2E2NGE5M2JhZTA0ZGY4OGM0MWI5NGRmOTc1Y2EzYV8yLTAtMS0xLTE2NzU0OA_55874bb4-b1a6-4c49-bd48-5c23151e7d5a">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6OGNhNjRhOTNiYWUwNGRmODhjNDFiOTRkZjk3NWNhM2EvdGFibGVyYW5nZTo4Y2E2NGE5M2JhZTA0ZGY4OGM0MWI5NGRmOTc1Y2EzYV8zLTAtMS0xLTE2NzU0OA_894789f9-2214-445c-acd0-2160c0324812">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.280%"><tr><td style="width:1.0%"></td><td style="width:32.903%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6ODRmOGFlNTYxNmZhNDBmM2FiNTUxZWY5Yzk2OWIxZTYvdGFibGVyYW5nZTo4NGY4YWU1NjE2ZmE0MGYzYWI1NTFlZjljOTY5YjFlNl8xLTAtMS0xLTE2NzU0OA_5335b153-b55d-4f81-a8d7-50b4622b0edb">Common stock ($0.001 par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6ODRmOGFlNTYxNmZhNDBmM2FiNTUxZWY5Yzk2OWIxZTYvdGFibGVyYW5nZTo4NGY4YWU1NjE2ZmE0MGYzYWI1NTFlZjljOTY5YjFlNl8xLTItMS0xLTE2NzU0OA_3af8f1c9-ab53-4059-81e1-e60ff4de6d44">NEO</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6ODRmOGFlNTYxNmZhNDBmM2FiNTUxZWY5Yzk2OWIxZTYvdGFibGVyYW5nZTo4NGY4YWU1NjE2ZmE0MGYzYWI1NTFlZjljOTY5YjFlNl8xLTQtMS0xLTE2NzU0OA_d147130e-f328-4228-b3cb-f61f284539ed">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yMDcx_4fe82490-f56d-4c16-86ca-f953030e14dc">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;&#160;</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.02</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Results of Operations and Financial Condition.</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8xMDk5NTExNjI5ODY1_b02090ba-16ff-432a-8a85-dd74fa47086d">May&#160;8, 2023</ix:nonNumeric>, NeoGenomics, Inc. issued a press release reporting its results for its first fiscal quarter of 2023. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This information shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.01</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    Not applicable</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)    Not applicable</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)    Not applicable</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)    Exhibits.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a99-103312023earningsrelea.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a99-103312023earningsrelea.htm">Press Release of NeoGenomics, Inc. dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a99-103312023earningsrelea.htm">May 8, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a99-103312023earningsrelea.htm">.</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:14.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.030%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NEOGENOMICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6NjcxZjkzMzRhYWQwNDI1NGEwMDVhOGQ0ZTIwZDM1ZGUvdGFibGVyYW5nZTo2NzFmOTMzNGFhZDA0MjU0YTAwNWE4ZDRlMjBkMzVkZV8yLTEtMS0xLTE3Nzk3MQ_b02090ba-16ff-432a-8a85-dd74fa47086d">May 8, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Jeffrey S. Sherman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey S. Sherman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a99-103312023earningsrelea.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i64bbb01270574d00a252a7c41b16e5f4_1"></div><div style="min-height:54pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.485%"><tr><td style="width:1.0%"></td><td style="width:46.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><img alt="earnings_header002a.jpg" src="earnings_header002a.jpg" style="height:159px;margin-bottom:5pt;vertical-align:text-bottom;width:235px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div></td></tr></table></div></div><div style="padding-right:-27pt;text-align:center;text-indent:-36pt"><font><br></font></div><div style="padding-right:-27pt;text-align:center;text-indent:-36pt"><font><br></font></div><div style="padding-right:-27pt;text-align:center;text-indent:-36pt"><font><br></font></div><div style="padding-right:-27pt;text-align:center;text-indent:-36pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">NeoGenomics Reports First Quarter 2023 Results</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">First Quarter Revenue Increased 17% to $137 Million</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Fort Myers, Florida (May 8, 2023) - NeoGenomics, Inc. (NASDAQ&#58; NEO) (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">a leading provider of cancer-focused genetics testing services and global oncology contract research services, today announced its first-quarter results for the period ended March 31, 2023. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Highlights</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:14.15pt">Consolidated revenue increased 17% to $137&#160;million</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:14.15pt">Clinical Services revenue increased 16% to $115&#160;million</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:14.15pt">Pharma Services revenue increased 22% to $22&#160;million</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Our business continued the momentum we saw in the fourth quarter of last year into the first quarter with accelerated double-digit revenue growth in both the Clinical and Pharma businesses,&#8221; said Chris Smith, Chief Executive Officer of NeoGenomics. &#8220;The key strategic initiatives set forth in second half of 2022 are continuing to have a positive impact on the business. Thanks to the strong execution of our Neo teammates and the growing demand for our tests from our existing client base and new customers, we continued to generate significant operating leverage as revenue favorability contributed to a significant improvement in AEBITDA.&#8221;</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">First-Quarter Results</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consolidated revenue for the first quarter of 2023 was $137&#160;million, an increase of 17% over the same period in 2022. Clinical Services revenue of $115&#160;million was an increase year-over-year of 16%. Clinical test volume</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> increased by 7% year-over-year. Average revenue per clinical test (&#8220;revenue per test&#8221;) increased by 8% to $402. Pharma Services revenue increased by 22% to $22&#160;million compared to the first quarter of 2022.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consolidated gross profit for the first quarter of 2023 was $54.8&#160;million, an increase of 43.4% compared to the first quarter of 2022. This increase was primarily due to an increase in revenue partially offset by higher payroll and payroll-related costs and an increase in supplies expense. Consolidated gross profit margin, including amortization of acquired Inivata developed technology intangible assets, was 39.9%. Adjusted Gross Profit Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, excluding amortization of acquired Inivata developed technology intangible assets, was 43.5%.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Operating expenses for the first quarter of 2023 were $90&#160;million, flat when compared to the first quarter of 2022. Operating expenses included a decrease in non-cash stock-based compensation expense and professional fees. These decreases were partially offset by restructuring costs which were not included in the same period of 2022. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net loss for the quarter was $31&#160;million compared to net loss of $49&#160;million for the first quarter of 2022. </font></div><div id="i64bbb01270574d00a252a7c41b16e5f4_272"></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Adjusted EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> was negative $7&#160;million compared to negative $19&#160;million in the first quarter of 2022. Adjusted Net Loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">(2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">was $12&#160;million compared to Adjusted Net Loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of $25&#160;million in the first quarter of 2022.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash and cash equivalents and marketable securities totaled $418 million at quarter end.</font></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">2023 Financial Guidance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The Company revised its full-year 2023 guidance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, initially issued on February 23, 2023.</font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 2</font></div></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.875%"><tr><td style="width:1.0%"></td><td style="width:19.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.199%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FY 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initial FY 2023 Guidance</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revised FY 2023 Guidance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">YOY % Change from FY 2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$510</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$545</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$555</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$555</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$565</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(144)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(116)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(107)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(116)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(108)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(48)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(27)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(22)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(22)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(18)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">________________________________________</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Clinical tests exclude tests and revenue for Pharma Services.</font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has provided adjusted financial information that has not been prepared in accordance with GAAP, including Adjusted EBITDA, Adjusted Gross Profit Margin, Adjusted Net Loss, and Adjusted Diluted EPS. Each of these measures is defined in the section of this report entitled &#8220;Use of Non-GAAP Financial Measures.&#8221; See also the tables reconciling such measures to their closest GAAP equivalent.</font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company reserves the right to adjust this guidance at any time based on the ongoing execution of its business plan. Current and prospective investors are encouraged to perform their own due diligence before buying or selling any of the Company&#8217;s securities, and are reminded that the foregoing estimates should not be construed as a guarantee of future performance.</font></div><div style="margin-top:12pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Conference Call</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has scheduled a webcast and conference call to discuss its first quarter 2023 results on Monday, May 8, 2023 at 4&#58;30 p.m. Eastern Time. To access the live call via telephone, interested investors should dial (888) 506-0062 (domestic) and (973) 528-0011 (international) at least five minutes prior to the call. The participant access code provided for this call is 357448. The live webcast may be accessed by visiting the Investor Relations section of our website at ir.neogenomics.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company&#8217;s website.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About NeoGenomics, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company&#8217;s also serves pharmaceutical clients in clinical trials and drug development.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NeoGenomics is committed to connecting patients with life altering therapies and trials. We believe that, together, with our partners, we can help patients with cancer today and the next person diagnosed tomorrow. In carrying out these commitments, NeoGenomics adheres to relevant data protection laws, provides transparency and choice to patients regarding the handling and use of their data through our Notice of Privacy Practices, and has invested in leading technologies to secure the data we maintain.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories for full-service sample processing in Fort Myers, Florida&#59; Aliso Viejo and San Diego, California&#59; Research Triangle Park, North Carolina&#59; and Houston, Texas&#59; and CAP accredited full-service, sample-processing laboratories in Rolle, Switzerland&#59; Singapore and China. CAP accreditation is pending in Cambridge, United Kingdom. NeoGenomics also has several, small, non-processing laboratory locations across the United States for providing analysis services. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.</font></div><div id="i64bbb01270574d00a252a7c41b16e5f4_4"></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward Looking Statements</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;project,&#8221; &#8220;guidance,&#8221; &#8220;plan,&#8221; &#8220;potential&#8221; and other words of similar meaning, although not all forward-looking statements include these words. These forward-looking statements address various matters, including statements regarding improving operational efficiency, returning to profitable growth and its ongoing executive recruitment process. Each forward-looking statement contained in this press release is subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company&#8217;s </font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 3</font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ability to identify and implement appropriate financial and operational initiatives to improve performance, to identify and recruit executive candidates, to continue gaining new customers, respond to the effects of the COVID-19 outbreak, offer new types of tests, integrate its acquisitions and otherwise implement its business plan, and the risks identified under the heading &#8220;Risk Factors&#8221; contained in the Company&#8217;s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and the Company&#8217;s other filings with the Securities and Exchange Commission. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We caution investors not to place undue reliance on the forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC, available at www.sec.gov, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document (unless another date is indicated), and we undertake no obligation to update or revise any of these statements. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">For further information, please contact&#58;</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NeoGenomics, Inc.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Kendra Sweeney</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Investor Relations and Communications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">M&#58; 239-877-7474</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">kendra.sweeney&#64;neogenomics.com</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 4</font></div></div><div style="padding-left:8pt;padding-right:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NeoGenomics, Inc.</font></div><div style="padding-left:7pt;padding-right:7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="padding-left:7.5pt;padding-right:7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</font></div><div style="padding-left:7.5pt;padding-right:7.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:61.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,609&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,180&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Marketable securities, at fair value</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,306&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,809&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,842&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,711&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventories</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,432&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,277&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaid assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,185&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,237&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,622&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,077&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,996&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,291&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,845&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,499&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,784&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,109&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,477&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,260&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,766&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,766&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total non-current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124,178&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,743&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709,174&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740,034&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable and other current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,634&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,278&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current portion of equipment financing obligations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current portion of operating lease liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,934&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,584&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total current liabilities</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,606&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,932&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Convertible senior notes, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,037&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535,322&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Operating lease liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,319&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,952&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred income tax liabilities, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,715&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,750&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other long-term liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,035&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,055&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total long-term liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,106&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,079&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734,712&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742,011&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,462&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,023&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709,174&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740,034&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:0.8pt;text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 5</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NeoGenomics, Inc.</font></div><div style="padding-left:6.5pt;padding-right:6.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="padding-left:133.5pt;padding-right:133.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</font></div><div style="padding-left:133.5pt;padding-right:133.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="padding-left:133.5pt;padding-right:133.5pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET REVENUE</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,869&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,791&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Services</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,351&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,378&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,220&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,169&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COST OF REVENUE</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,406&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,937&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GROSS PROFIT</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,814&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,232&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,549&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,248&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,395&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,713&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,259&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,299&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,684&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,887&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,260&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LOSS FROM OPERATIONS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,073)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,028)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,467)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,720)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,161)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,925)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,753)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET LOSS</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,795)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,408)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET LOSS PER SHARE</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.40)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.40)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE COMMON SHARES OUTSTANDING</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,026&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,630&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,026&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,630&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 6</font></div></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NeoGenomics, Inc.</font></div><div style="padding-left:36.5pt;padding-right:36.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </font></div><div style="padding-left:37.5pt;padding-right:37.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</font></div><div style="padding-left:37.5pt;padding-right:37.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="padding-left:37.5pt;padding-right:37.5pt;text-align:center"><font><br></font></div><div style="padding-left:19.5pt;padding-right:19.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.972%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,795)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,408)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net&#160;cash&#160;used in operating&#160;activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,048&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,395&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,783&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,490&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock-based compensation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,758&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,103&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,330&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of convertible debt discount and debt issue costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of assets held for sale</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,048)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,423)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,057)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,692)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,040)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,756)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,167)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of marketable securities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,425&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,438&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,927)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,219)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by investing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,742&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,052&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of equipment financing obligations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,411&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,403&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,057&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,429&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,931)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,180&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,827&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,609&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305,896&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 7</font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Measures</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to provide greater transparency regarding our operating performance, the financial results and financial guidance in this press release refer to certain non-GAAP financial measures that involve adjustments to GAAP results. Non-GAAP financial measures exclude certain income and&#47;or expense items that management believes are not directly attributable to the Company&#8217;s core operating results and&#47;or certain items that are inconsistent in amounts and frequency, making it difficult to perform a meaningful evaluation of our current or past operating performance. Management believes that the presentation of operating results using non-GAAP financial measures provides useful supplemental information to investors by facilitating the analysis of the Company&#8217;s core test-level operating results across reporting periods and when comparing those same results to those published by our peers. These non-GAAP financial measures may also assist investors in evaluating future prospects. Management also uses non-GAAP financial measures for financial and operational decision making, planning and forecasting purposes and to manage the business. These non-GAAP financial measures do not replace the presentation of financial information in accordance with U.S. GAAP financial results, should not be considered measures of liquidity, and are unlikely to be comparable to non-GAAP financial measures provided by other companies.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definitions of Non-GAAP Measures</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-GAAP Adjusted EBITDA</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Adjusted EBITDA&#8221; is defined by NeoGenomics as net (loss) income from continuing operations before&#58; (i) interest (income) expense, net, (ii) tax (benefit) or expense, (iii) depreciation and amortization expense, (iv) non-cash stock-based compensation expense, and, if applicable in a reporting period, (v) acquisition and integration related expenses, (vi) restructuring charges, and (vii) other significant or non-operating (income) or expenses, net.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-GAAP Adjusted Cost of Revenue, Adjusted Gross Profit and Adjusted Gross Profit Margin</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Adjusted cost of revenue&#8221; is defined by NeoGenomics as cost of revenue before&#58; (i) amortization expense of acquired Inivata developed technology intangible assets, and, if applicable in a reporting period, (ii) the write-off of COVID-19 PCR testing inventory equipment. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Adjusted gross profit&#8221; is defined by NeoGenomics as total revenue less adjusted cost of revenue. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Adjusted gross profit margin&#8221; is defined by NeoGenomics as adjusted cost of revenue divided by total revenue.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-GAAP Adjusted Net (Loss) Income</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Adjusted net (loss) income&#8221; is defined by NeoGenomics as net (loss) income from continuing operations plus&#58; (i) non-cash amortization of intangible assets, (ii) non-cash stock-based compensation expense, and, if applicable in a reporting period, (iii) acquisition and integration related expenses, (iv) restructuring charges, and (v) other significant or non-operating (income) or expenses, net. If GAAP net (loss) income is negative and adjusted net (loss) income is positive, adjusted net (loss) income will also be adjusted to reverse any recognized interest expense (including any amortization of discounts) on the convertible notes using the if-converted method unless the effect of this adjustment on both the adjusted net (loss) income and weighted average diluted common shares outstanding would be anti-dilutive. If GAAP net (loss) income is positive and adjusted net (loss) income is negative, adjusted net (loss) income will also be adjusted to reverse any recognized interest expense (including any amortization of discounts) on the convertible notes using the if-converted method.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-GAAP Adjusted Diluted EPS</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Adjusted diluted EPS&#8221; is defined by NeoGenomics as adjusted net (loss) income divided by adjusted diluted shares outstanding. If GAAP net (loss) income is negative and adjusted net (loss) income is positive, adjusted diluted shares outstanding will also include any options or restricted stock that would be outstanding as dilutive instruments using the treasury stock method and the weighted average number of common shares that would be outstanding if the convertible notes were converted into common stock on the original issue date based on the number of days such common shares would have been outstanding in the reporting period, until the effect of these adjustments are anti-dilutive. If GAAP net (loss) income is positive and adjusted net (loss) income is negative, adjusted diluted shares outstanding will exclude any options or restricted stock that would be outstanding as dilutive instruments using the treasury stock method and the weighted average number of common shares that would be outstanding if the convertible notes were converted into common stock on the original issue date based on the number of days such common shares would have been outstanding in the reporting period.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 8</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP Net Loss to Non-GAAP EBITDA and Adjusted EBITDA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:9.5pt;padding-right:9.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.255%"><tr><td style="width:1.0%"></td><td style="width:68.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.399%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.894%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss (GAAP)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,795)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,408)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to net loss&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,467)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,925)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,753)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,048&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,395&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,783&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,490&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBITDA (non-GAAP)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,356)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,975)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Further adjustments to EBITDA&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration related expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock-based compensation expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,758&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,103&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,684&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant (income) expenses, net</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA (non-GAAP)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,116)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,011)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________</font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, other significant (income) expenses, net, includes CEO transition costs, fees related to a regulatory matter, and other non-recurring items. For the three months ended March 31, 2022, other significant (income) expenses, net, includes a gain on the sale of a building, fees related to the regulatory matter, CEO transition costs, and other non-recurring items.</font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 9</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of Segment and Consolidated GAAP Cost of Revenue, Gross Profit and Gross Profit Margin to </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Adjusted Cost of Revenue, Adjusted Gross Profit and Adjusted Gross Profit Margin</font></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</font></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="padding-left:23.5pt;padding-right:23.5pt;text-align:center"><font><br></font></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"></td><td style="width:52.193%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Clinical Services&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue (GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,869</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,791</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of revenue (GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,292</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,267</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to cost of revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,264)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,264)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted cost of revenue (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,028</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,003</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit (GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,577</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,524</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted gross profit (non-GAAP )</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,841</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,788</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin (GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted gross profit margin (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Pharma Services&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue (GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,351</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,378</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of revenue (GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,114</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,670</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to cost of revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(589)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted cost of revenue (non-GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,525</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,081</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit (GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,237</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,708</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted gross profit (non-GAAP )</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,826</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,297</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin (GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted gross profit margin (non-GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Consolidated&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue (GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,220</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,169</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of revenue (GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,406</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,937</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to cost of revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)(6)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,853)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,853)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted cost of revenue (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,553</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,084</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit (GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,814</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,232</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted gross profit (non-GAAP )</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,667</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,085</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin (GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted gross profit margin (non-GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________</font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Clinical Services cost of revenue adjustments for both the three months ended March 31, 2023 and 2022 includes $4.3 million of amortization of acquired Inivata developed technology intangible assets. </font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharma Services cost of revenue adjustments for both the three months ended March 31, 2023 and 2022 include $0.6 million of amortization of acquired Inivata developed technology intangible assets. </font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 10</font></div></div><div style="margin-top:12pt;padding-left:15pt;padding-right:15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP Net Loss to Non-GAAP Adjusted Net Loss </font></div><div style="padding-left:15pt;padding-right:15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and GAAP EPS to Non-GAAP Adjusted EPS</font></div><div style="padding-left:8pt;padding-right:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</font></div><div style="padding-left:15pt;padding-right:15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="padding-left:15pt;padding-right:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.660%"><tr><td style="width:1.0%"></td><td style="width:68.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss (GAAP)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,795)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,408)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to net loss, net of tax&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,783&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,490&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration related expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock-based compensation expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,758&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,103&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,684&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant (income) expenses, net</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net loss (non-GAAP)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,772)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,954)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per common share (GAAP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Diluted EPS</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.40)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to diluted loss per share&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration related expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock-based compensation expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other significant (income) expenses, net</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rounding and impact of diluted shares in adjusted diluted shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted diluted EPS (non-GAAP)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares used in computation of adjusted diluted EPS&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted common shares (GAAP)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,026&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,630&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of options, restricted stock, and converted shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)(10)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted diluted shares outstanding (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,026&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,630&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________</font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> For the three months ended March 31, 2023, other significant (income) expenses, net, includes CEO transition costs, fees related to a regulatory matter and other non-recurring items. For the three months ended March 31, 2022, other significant (income) expenses, net, includes a gain on the sale of a building, fees related to the regulatory matter, CEO transition costs, and other non-recurring items. </font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> This adjustment is for rounding and, in those periods in which GAAP net (loss) income is negative and adjusted net (loss) income is positive or GAAP net (loss) income is positive and adjusted net (loss) income is negative, also compensates for the effects of additional diluted shares included or excluded in adjusted diluted shares outstanding for the treasury stock impact of outstanding stock options and restricted stock and the if-converted impact of convertible notes.</font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In those periods in which GAAP net (loss) income is negative and adjusted net (loss) income is positive, this adjustment includes any options or restricted stock that would be outstanding as dilutive instruments using the treasury stock method and the weighted average number of common shares that would be outstanding if the convertible notes were converted into common stock on the original issue date based on the number of days such common shares would have been outstanding in the reporting period, until the effect of these adjustments are anti-dilutive.</font></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In those periods in which GAAP net (loss) income is positive and adjusted net (loss) income is negative, this adjustment excludes any options or restricted stock that would be outstanding as dilutive instruments using the treasury stock method and the weighted average number of common shares that would be outstanding if the convertible notes were converted into common stock on the original issue date based on the number of days such common shares would have been outstanding in the reporting period.</font></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><font><br></font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 11</font></div></div><div style="padding-left:34.5pt;padding-right:34.5pt;text-align:center;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> Reconciliation of Non-GAAP Financial Guidance to Corresponding GAAP Measures </font></div><div style="padding-left:34.5pt;padding-right:34.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</font></div><div style="padding-left:34.5pt;padding-right:34.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP net loss in 2023 will be impacted by certain charges, including&#58; (i) expense related to the amortization of intangible assets, (ii) non-cash stock based compensation, (iii) restructuring charges and (iv) other one-time expenses. These charges have been included in GAAP net loss available to stockholders and GAAP net loss per share&#59; however, they have been removed from adjusted net loss and adjusted diluted net loss per share.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the Company&#8217;s 2023 outlook for net loss and EPS to the corresponding non-GAAP measures of adjusted net loss, adjusted EBITDA, and adjusted diluted EPS&#58;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31, 2023</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low Range</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High Range</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss (GAAP)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,000)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,000)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock-based compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other one-time expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net loss (non-GAAP)</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,000)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,000)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,000)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA (non-GAAP)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,000)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,000)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per diluted share (GAAP)</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.91)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.84)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to net loss per diluted share&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock-based compensation expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other one-time expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rounding and impact of diluted shares in adjusted diluted shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted diluted EPS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> (non-GAAP)</font></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.36)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.30)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average assumed shares outstanding in 2023&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares (GAAP)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options, restricted stock, and converted shares not included in diluted shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted diluted shares outstanding (non-GAAP)</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________</font></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> This adjustment is for rounding and, in those periods in which GAAP net (loss) income is negative and adjusted net (loss) income is positive, also compensates for the effects of additional diluted shares included in adjusted diluted shares outstanding for the treasury stock impact of outstanding stock options and restricted stock and the if-converted impact of convertible notes.</font></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> For those periods in which GAAP net (loss) income is negative and adjusted net (loss) income is positive, this adjustment includes any options or restricted stock that would be outstanding as dilutive instruments using the treasury stock method and the weighted average number of shares that would be outstanding if the convertible notes were converted into common stock on the original issue date based on the number of days such shares would have been outstanding in the reporting period, until the effect of these adjustments are anti-dilutive.</font></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">  Page </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">&#124; 12</font></div></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Information</font></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Tests Performed and Revenue</font></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="padding-left:38pt;padding-right:38pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.107%"><tr><td style="width:1.0%"></td><td style="width:52.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clinical</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58;</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of tests performed</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,476&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,035&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average revenue&#47;test</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________</font></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Clinical tests exclude tests and revenue for Pharma Services.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-right:-9pt;text-align:center"><font><br></font></div><div style="padding-right:-9pt;text-align:center"><font><br></font></div><div style="padding-right:-9pt;text-align:center"><font><br></font></div><div style="height:30.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NeoGenomics, Inc.  &#124;  9490 NeoGenomics Way  &#124;  Fort Myers, FL 33912</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>neo-20230508.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d3fe8359-94c4-4e01-8695-3cfc87e375dc,g:093795f1-7a86-4f35-b36e-e687fc3845d6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:neo="http://neogenomics.com/20230508" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://neogenomics.com/20230508">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="neo-20230508_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="neo-20230508_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://neogenomics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>neo-20230508_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d3fe8359-94c4-4e01-8695-3cfc87e375dc,g:093795f1-7a86-4f35-b36e-e687fc3845d6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityAddressAddressLine1_e6acbff9-05ae-4a1e-b6c8-faf487a24f85_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_f080de74-e448-410a-8d38-1e6510dd1e41_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_3b80435f-1ad1-43d6-baf2-9f2dcbbfdb8c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_330b7cf4-cacc-4a97-85af-09f7c3e60b20_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8dcce39c-2f76-448f-a2c3-7d0daa4c9e55_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_dea7422c-81ff-42e5-8b34-9a7469563865_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e21457f6-3a67-4949-a6bc-5a5b754f0a4b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c28debe9-aa0d-4b2a-b94d-7a600d1297d5_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fafa14cf-6b20-4bfd-886c-da6e8b7e68cc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_fe8968f9-5453-4b0d-a6b3-381d404f28be_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7f7acd23-ac66-4d5c-94a3-6104728b897d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_38bd11a9-9587-4917-b8e4-712c2ebb401a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_18cf7a0c-0300-4fb4-b1b8-9d338ab34873_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_65cbaf8a-f08e-4471-91ad-05985dae35ca_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_fcff98c0-155b-42d9-ba0c-a4c8e3bbcd2b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4496db49-5232-451a-a05d-f85cc1d2d37d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b62f4628-79c5-45ca-a22c-ae70d0e4a79a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_07af5dc0-ebb7-4927-9320-fa12fbddf237_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3782e138-5aa3-404b-ad15-02d096bb4960_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_89bddf31-3186-4fde-8e29-5c47d820ebca_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_acdcd45f-1ae7-41cd-8321-4b696ca6b03f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f48a333b-c423-4b2b-ab76-500d4c0e7bb7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_840ef794-7edf-453c-aa58-989e61846148_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>neo-20230508_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d3fe8359-94c4-4e01-8695-3cfc87e375dc,g:093795f1-7a86-4f35-b36e-e687fc3845d6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://neogenomics.com/role/Cover" xlink:type="simple" xlink:href="neo-20230508.xsd#Cover"/>
  <link:presentationLink xlink:role="http://neogenomics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a7b5cef6-0aad-4fb8-98c0-b2bbe8aa8f60" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_DocumentType_a7b5cef6-0aad-4fb8-98c0-b2bbe8aa8f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c409aeae-9cc6-4d08-bddd-e2330d55def1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_DocumentPeriodEndDate_c409aeae-9cc6-4d08-bddd-e2330d55def1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d3cbfdaf-2891-4f5b-9a6d-41b131e7bbf2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityRegistrantName_d3cbfdaf-2891-4f5b-9a6d-41b131e7bbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_239260c1-ba27-46e4-838a-d4db9ec863b3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityCentralIndexKey_239260c1-ba27-46e4-838a-d4db9ec863b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f1690075-520f-4fb5-8ddf-cf06f082e569" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_AmendmentFlag_f1690075-520f-4fb5-8ddf-cf06f082e569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_faa9f630-245e-42b9-804e-50c5d4ee14f2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityIncorporationStateCountryCode_faa9f630-245e-42b9-804e-50c5d4ee14f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c510540c-1a81-4df0-8815-b42a324b38aa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityFileNumber_c510540c-1a81-4df0-8815-b42a324b38aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_dae8bd96-0f04-48ff-8122-f662da451f48" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityTaxIdentificationNumber_dae8bd96-0f04-48ff-8122-f662da451f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_af645267-f8f4-4f63-ab21-4c2fbdca3fac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityAddressAddressLine1_af645267-f8f4-4f63-ab21-4c2fbdca3fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_35a0dded-96b2-4fb9-a068-812d8d365a73" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityAddressAddressLine2_35a0dded-96b2-4fb9-a068-812d8d365a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b3e6238a-41bf-4bfc-bbe6-a053312e9d06" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityAddressCityOrTown_b3e6238a-41bf-4bfc-bbe6-a053312e9d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_77727e84-ecb9-4e2f-8a4b-624977655db1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityAddressStateOrProvince_77727e84-ecb9-4e2f-8a4b-624977655db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2cbda7f8-6fc1-47d5-8c65-cf2c7a56ebee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityAddressPostalZipCode_2cbda7f8-6fc1-47d5-8c65-cf2c7a56ebee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_feb8b22a-3c41-4bcc-94f3-8f1e2343b8f9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_CityAreaCode_feb8b22a-3c41-4bcc-94f3-8f1e2343b8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3751646f-106a-41d0-96f0-f45530259cdc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_LocalPhoneNumber_3751646f-106a-41d0-96f0-f45530259cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_460326cb-bf91-46ae-8b89-5836b40e0b1e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_WrittenCommunications_460326cb-bf91-46ae-8b89-5836b40e0b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_4653675a-a847-4b1b-ba25-9fa6b48a763e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_SolicitingMaterial_4653675a-a847-4b1b-ba25-9fa6b48a763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6281e136-4877-46dc-88cc-c7fc4df42b59" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_PreCommencementTenderOffer_6281e136-4877-46dc-88cc-c7fc4df42b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_67e03fbe-d24b-4385-9acc-3c2eaa5c0498" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_67e03fbe-d24b-4385-9acc-3c2eaa5c0498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_00845438-497c-4d0d-bed1-32a00cc9db39" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_Security12bTitle_00845438-497c-4d0d-bed1-32a00cc9db39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_160fc359-0650-4c26-acac-523bdf198171" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_TradingSymbol_160fc359-0650-4c26-acac-523bdf198171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6182e715-bae7-4ec8-b6d0-d89d029dc48a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_SecurityExchangeName_6182e715-bae7-4ec8-b6d0-d89d029dc48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_09f4e881-d5fc-46c4-97fa-efd211fa6201" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19c35a8c-9fc7-481e-9ac1-d29a6743c954" xlink:to="loc_dei_EntityEmergingGrowthCompany_09f4e881-d5fc-46c4-97fa-efd211fa6201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>earnings_header002a.jpg
<TEXT>
begin 644 earnings_header002a.jpg
MB5!.1PT*&@H    -24A$4@   E$   &3" 8    (M$?\     7-21T( KLX<
MZ0    1G04U!  "QCPO\804    )<$A9<P  'L(  ![" 6[0=3X  /^E241!
M5'A>['T'8"57>?5Y_:E+J^W59=U[;U0;,+;IO1D(D 0"24@@0&@!0DQ"J"$)
MY _-@&FAFF)CC(V-C;O7=6VO[?5Z>]6J2Z_-_.=\=^;I2=Z59':E?9+OV1V]
MF3OWWKGEN]]W;ID[B9" AX>'AX>'A\<,P[M6;\27'^Y%D$T@03:3H%O OTF$
M"!))YRDA5R*B._+G0)^%,CYV]#)\\(AVI"(W,/1D,7F?'AX>'AX>'AYU G&A
M):E&!")'XDED1W)+\;S*DP3=W\-X49C,D&BE\7AYR!$H\:<G"4^B/#P\/#P\
M/&8<-**4)F,R_E1#@.()MD081(==5A%& U..:06@%P=C1$^.%GD2Y>'AX>'A
MX3$#$:"4++E3$J=$Q(Z>..8T9H@I0>*E(ZR0@ 7((LTPM7XF/R3E292'AX>'
MAX?'C(,X4TLJ73VWWYIINWC 21@[&F4(29X2&>P(RD@$M;XG#T^B/#P\/#P\
M/&8<M'R\):%1)%UH3"E$,N)",24:H48:71H981)G"I-EG:$05LB&:EG6Y*F1
M)U$>'AX>'AX>,P_D/<EX05/@2)!&I.+1*/W54254YCQ"I+1>2HNI&LW'B/N3
MV;3 DR@/#P\/#P^/&0<1IE22-$9;&)#XI!))(T!RVQL-,B(5DZQDBG]2" -1
M(3<M*&B]U&3A292'AX>'AX?'C$1_4(K9%"JV4-P1J5H:] 1"%9&D1$#_ 3 8
M^XY&LVQ4:F\L; P\B?+P\/#P\/"8D6C/9DB@*K:D26_GB4 E28K&XT )DB4=
M0LB A4J9!(S$*5Y01<0+U2>")U$>'AX>'AX>,P[B.=E$ DD2(EO'E$B1!R6,
M$(U/@GB?_F,_0>"N!?<[>6KD292'AX>'AX?'S /YSG"I1!+D=BH/]9:=0"*U
MQRT-(H@[)>5!_GCD4DFD;11*"\T=LQHO?"T\B?+P\/#P\/"8>2#?"=(9_O(@
M4B1"VKH@GJK;$QQ%BA!J@\X022U.CZ_=V:3A292'AX>'AX?'C$0QT.A1RD:4
MM$^4@61J(C)D.Y;3/T.C'%1X)CKD/D'L1J2BTPG@292'AX>'AX?'C(0V)DBB
M3!)$ A7JW3R2J6A]TYZ@.W;(3[0HJDS.9.&KQ&GRU,B3* \/#P\/#X\9"7WV
M)2"),F9$2J-%XEI</MY77&Q1>4RTY%]OZT6$*G*M.1D?GD1Y>'AX>'AXS#B(
MY_25BG:>2*00)@*D(P*5"/=.;VPS31T1!6I(:8'Y&-[D.-6$\"3*P\/#P\/#
M8^8A#%&R=4P)A$$9VBQ3:YS&WR6J%@')4XA4*EX+-6GN5(4G41X>'AX>'AXS
M#AI1*ACM(0DBFTDFT^11,0T2G9H883(1;6_PY F4X$F4AX>'AX>'QPQ$@*!4
M-#)EGWNID#@EM;[)$:P)$6T&5=U?2H@&L28[EN5)E(>'AX>'A\<,1!)-N1Q"
M;7,0D$9I5L[VB'*??YD4&$[[2DV6-(V%)U$>'AX>'AX>,PXB/L-:6)[0=%X*
M%;UIETQ.2(@T1E4[3I71PO+H/#Z9Q#B6P9,H#P\/#P\/CYF',,2@IO!L-DZ+
MQ-T(E YM<S 9R%>^9F'YDX4G41X>'AX>'AXS#B)-PZ0QB40283(>?](UJ=$X
MGWX9!?K+BD29]YK%Z),,[DF4AX>'AX>'QXS$SG*9!(HGI=#>M!,I$HD:=[/-
MZ+ =RQFF)5Y8SHBJGXX9)WPM/(GR\/#P\/#PF($(D"R1QI $::^G9,61HM"V
M.= '8<:'O&GJ;UZ^B:2+Y$G!^<<6I4=<:B)X$N7AX>'AX>$Q Y%$5[ED9Y5X
MNP(2(7V*.*%/P4R >"N$_F XWNW ")0M,Q</FP0\B?+P\/#P\/"8<=#^Y$TI
MC41IY"B)(!D@%6I]4YKG6BPNBC,QS6G0FBB2*?$H6T_%_Q&GFA">1'EX>'AX
M>'C,.&BP:,C60-F0DHTFV52<$/^.A\A/)5%Q(U%&QFKBF 0\B?+P\/#P\/"8
M>0B3V%PJN]$C5$AH4@A29?L0\>C=HD:/2,FW#I&ED&&7IQIL&E!$3$1*TWFZ
MG P\B?+P\/#P\/"8>2!92B72Y#UN),G6,P6D3V1$;G'Y6(RF/$:^0I(P;6U@
MY,D<'<.:)#R)\O#P\/#P\)AQ&"H!.XL#"!,97KDU46YF3RRH9L^GO<"F[9))
MY'(9AM'(%<.(5[G;DX(G41X>'AX>'AXS#F62IKXB:4Q2ZZ%$@,B ] %B(U%[
MHS>:Z','$A4D,UDLRD;749@G,1 5A?#P\/#P\/#PF$$(@S12J0Q0*9/-)-P^
M44$"05 FN9D,%4HC+%7<B)0AJ)Y/=C3*DR@/#P\/#P^/&8>N0@F;!_N!5!)A
MA01(GW_18%0B))&:>#I/GM.9$(WID6_G:11+.TS9[-XDX$F4AX>'AX>'QXQ#
M=QB@F,SR3.1);^2Y:;Q TWLVI3<^$N42YC8DL2BOM_$"_F,8DB>C5),9R"(\
MB?+P\/#P\/"8<1@N5TAX2&."!%(D3FXQ.0^]G3<)$A0F&S%<2F.P1,]!TDB8
M??XE_I;>).!)E(>'AX>'A\>,0W\Y1/]PP:;S G*?BK8KX&]R$C-Y0@(E:!PK
M(RH4L2$M,=<HUB1G\SR)\O#P\/#P\)AYV% LHV1L)T283)'\:*L"-PHU&2*E
M1>0=#6DT9T2=Y&#.]C/)V3Q/HCP\/#P\/#QF'G8-5QS;"0.DRCS1]_-$J'0Z
M&19$3TNR*71F;3648T^D10G&$_&I">%)E(>'AX>'AT=]@FQ&A*9*:FK834GO
MT94U%4<*I,7D2=UT:YLF1Z)*2 3R6)W+<Z#39((+GD1Y>'AX>'AXU"<B0F-;
M#NC@1<RC<DCS;T W.@;AR'Y/]E'B\6F0_&K$J3&M./YT>!+EX>'AX>'A4;<P
M<F1,REW'A&K 1I$<;!J/OS%YJA*J"=">23E6QJ,:1N?N;$)X$N7AX>'AX>%1
MOZA]6TXG$:%:/S0,5-QZIE [EL<C4L:C)J(W6O>4Q-R<>7:88/1J3_ DRL/#
MP\/#PZ,^0=+D1I[X)R)0VL5)HT:[RMI44]-RCE?%(TD:C7(C4A-0G#0P/T<_
M].K&L9X\/(GR\/#P\/#PJ$-$^Q3$ T1&=DA<2):T(+QO6)-X#K:8G+_V9A[O
M!Q&AVBO-T8::R006:#I/E_$S(HRYW"L\B?+P\/#P\/"H0^AS+N[,]G_2B0@4
M_VE_J!T5DBQ]-X^$:NPHU-Y(D!NA<I"O^=DTXXRO(R0FN5LGX4F4AX>'AX>'
M1UW"B(TX#8F.IMP29%4B5NM+_=A2&+31)"-&T9HH&X7BI4T!5K%GJI/-I-">
MRT17(Q@5= )X$N7AX>'AX>%1GQ"C$9,2,>*_,.D6DA<K>?24-147D#15JB-1
M@J;Z]$'BZJB4'2D2J^3(B!6)60>#+TT[4I8(Z1!%03K&OY,;C?(DRL/#P\/#
MPZ,^08(3+_IV7$I$".@MEE JE8P<)9..RH@@Q:0IIC=RJQYRCJ#KIE02>;<D
M*@I3B\G1(T^B/#P\/#P\/.H/\<A01'#(>PRZW%TN(X@&BT2(:A%?CW471D@6
M,+<AB]9,QLA9:,-1YNSPQ*![A"=1'AX>'AX>'G6(T5-JM8-%VXL5$ATZ1%-T
M3QQ)>B*<']$>'@S;QLMLRK$E4BORILE-X=7"DR@/#P\/#P^/^D."!"DZ'46H
MP@ [2_JMG;X;0>UU[?FH$2H>\_,9DJ"1)SB?T7-&1[E7>!+EX>'AX>'A47>H
MG8[3[N+57:%(KA[L+XHA\7 +R$<1I @Q@1I+LAR2F&][1$4TR+P\>4KD292'
MAX>'AX='W4%3;,9M(EZD#36%@:"">[L'Z6&$,-5"1&I/(U""G8>D/KR_-!]]
M?'@/T=2&&0^>1'EX>'AX>'C4'\B#;)U2=?-+_08HD43U)+)B.LZ9V!-QBH^]
MH2,[0H'B]5"Q_SV/7CT1GD1Y>'AX>'AXU!U$;&QO)YXG0NT%)<J2Q([A$+W#
M1=NM7&1G+('2N0Z%M+ !_1DW"I 45PI+C"9$9RH*HRE![="IYR6BS\#8WXGA
M292'AX>'AX='_2$:%2)%0JC-,L5SZ+2K'**O4K9[>X.(%2F130!J@TZW1U02
M%;*>D(RJ,9/"TL:\Q6=4**FW\QPE,E(V21;E292'AX>'AX='W2$>%:I"Q(8$
MY[&A$OI*91MMJMU <RP24'@W3>=&IJ(U5B1A^O#P(IO.J]#'Z&F_VE&MB>!)
ME(>'AX>'AT?=P:V'XO^(/ D!6<N&P2+"2M((5"WYB<]M)$D$*_K5$?#<R%)2
M!"F!EFP&;5F=IQRYDC\+K/_NN9.!)U$>'AX>'AX>]0GQ&2,XCMAHG=/.@IC.
MZ'500DR8=(R0*X:07YXEC(TQGB"!CC202T6KINBD/W$(H?9\/'@2Y>'AX>'A
MX5&'($4A^Q&AB0]A1TF[E3^1YH@LC9 GHOI6GR-8=J\D0I7$X:UY_CK"Y9XQ
M0H?<Q-_DX$F4AX>'AX>'1]W!B(S^&#%R="4(DU@_3!(E\A/!B% -;.0I<M/@
MDT(;P9)3(F7;1!W4R(N8<-4&CXE7$-V; )Y$>7AX>'AX>-0E[!T[$J*$+8#2
M1IL!-@P.&SF*B5+MZ)/YY6&DR5PT#>C\:;N$!/E7$F4<E$^3.VF24%LG5(Q'
MN3?RHIW1HS 3P9,H#P\/#P\/C[J#.(VFU@Q)D2E@\U"(;06>I$:3IQA&GB+W
MI )$>T"Y]5"*LXQ,/H-E^9PB9^S:.B%Z"S#B33:9%YU/!$^B/#P\/#P\/.H.
M51YC_,?1E:YR ;VE L+DF.T/]@!MLEG1ZWR,*0A)IA1/F$)',HN#2*3V!SR)
M\O#P\/#P\*A;Q%L95'B^>[",1%DC12.+QO>&P.;NTF[J+Z9D_&E/5="<&G^S
MSLG"DR@/#P\/#P^/^H.-0)$LV9HE-[%W6V^!I$C3<Z)4$T&C3[8(BB2,["G)
M"(,25C1GT9CS(U$>'AX>'AX>LQ4C@T?5D:<[^H<1\#Q,3(Z^:'V3QK"2R:2;
MTN._9?D,LO8=OGV')U$>'AX>'AX>=0<;B")-"9&RZ;PR2=".8=(6$B*$:;L[
M'O2]/853#$%01C*1YG422YHR1J;V!SR)\O#P\/#P\*@[1"_4&=W1=_"V#0;8
M4"J1N?#*-GV: #:%IVT,$N1=)%!:!D76<[ ^][)_.)0G41X>'AX>'AYU"",Z
M9:V*,CQ6*&'G4,'.@P3)U 2P3\4$%>-2_+%1J88<<$)K4SS,M<_P),K#P\/#
MP\.C3J%-,<EX$@&V#)51JFA?)RTTGWAA>*@]HA(I) /^VJ+R /-3*2QM\"-1
M'AX>'AX>'K,8&BS2Z)%;OY3$H\4B GTWC^?::7PBV*)RA6=$[MMX92QNRJ,M
MLW_>S!,\B?+P\/#P\/"H.]3N[Z3/OZS:53#6$N]6,!%L6P.&"Q(:S=)V!TD<
MTI">Q!C6Y.%)E(>'AX>'AT?]@1S(MMCD[W"E@G4#I"QB5F)0\:=:QD&H;^@E
MDC:MAXKVEDIA64[7NNG\["L\B?+P\/#P\/"H.XCGZ&/"FKK;7@ >*0R2M9 ,
M:8^G:-^H\2""(R)EG(D7(<,N:TPS7I$P\[+/\"3*P\/#HTZA]1SC'1X>LQG&
M<\A^])'@S8-%["X7Z:!KWM'K=A/!O9*',%!, ;)IX+"6#)(V%+5_X$F4AX>'
M1YU"O?#QCLDB)ER>>'G,+ 1NUHU_U@[SMYBR?3:U<68PR1W+JZ-696!18Q)'
M-C;8]?YJ"IY$>7AX>,Q2[(TT>3+E,3.09&=!GW@)<%OW(*\#!+:JG,=D^A#)
ME&UMH(TZ$T$%AS3DL(Q$2G@2?9!QD6!C\JUI0FCNU15\J \A[G%!FYN?=5_F
MX;^X5">H*!7_$WN4\5QOQ'$M+BVNBY\;IT<LW?UJUCC$R#;X]GR;,X[BB# J
M64%H<\0NK 9(1^)UT&;Y\EMF.K4W1Y1.YS@YT&\\<NK2I"UCF4YS5[KYO-KX
MF"9K($\"%ESAF+Z19ZGAV:!O74-OG+@TVH<)7'D0:I63:>2NZ&KK+:IOJUO=
M59SZU('BB^Z[0(::4W<AU'NA_2F(,QK]CLIW5&YQ*QAIXS7EN3=4(Y)?!Q>+
M$+M%=1/P&;R1E%$P/W'\(\]Q^D"1)K&KOXAMO25T]_6A=[B"_J$2M4 : T-%
M#!:*0(KURK@4DSZRVLX>ME9[9#,)-#9DT9S/85%'&O-;&M&D>8Q1^7;/=-<\
M9V_=VB,3:#IA= &9/Z&VG8VDW\-C"D&9"Y)EG'?S=ERW90")'.V1D2)*>U(R
MN&>8O9(>E!Q+OH=+>,?A[?CO8Q=&'MS/OL*3J$G!*8M*4,!PJ9=EGT(^.X<5
M4W;*5HJ%BB<F1*JT"L]3U$2Q@HI16]P*J^ND"8(($)4K \=*M-:HCL )C;[_
M8T967FM_[7G\3P)1YF^2:;,TQ;>)4>=\OJZ358$K4V S( =!6LJ>Z=&] N/=
MV5U@N#+F=C0C2[>QBG9OJ"6>+HCR$!D-NQZ=IB>#$-JU-GIA-2I_*\<H_C\E
MSNF&1,*504U=3;9 5-W,JOR;LB!4OB.&7/%+#GE5C<_)D%#K;U9",LVVJ1R/
MZOI$[LJ[VID(#I(EEB-E*2J02<MD;=DK$!'7I3M7/%+\+&NK+-5 A5<C*>HE
M05KU^&[<_,@N/+"Q&X]L&\#FW8/8M'L(Q1[VP$N,17I&4"=#[<_:J^+DKX3(
MOB>FNM8/R54FB>8%;5C6D<.A\UNQ;'X33EC>@G,.[<#1R^;&">.O=G2F48JO
MJZF+VFGTV/A>C%DO.QX''$XD VPIA#CCAG78T$M;DJ6LTLW>N)-\C@/)M-IA
M1>VA6,%G3IB/OSNDDW<F#CM9>!(U&43*I;NT'7=N_"X>Z[H#NP;6L<?7Q*/1
MOLD3:$=45E:*E26253%CR(JKEJY3-V8DQ5 , 8;"(N9D%N#<0]^-12U',V2D
MM"0@K)I +J,TU4CEBYS8Z)3\Z=ERXWUY_W_7KL4G?G@OO5*IIIQ_,[12LO0;
M(Z1C,LPR7-'2G.*M!"V"_$E)EH(*NGIT#WCVR@X\[=BE^+L+#D5;HY[K>K?C
MP0B44F8"'UA^9+K4<WYD^P"&ALM(IA5/7"8C4-G9>L ](!;;! W',0M:>:+R
M5MZTV%!EJ(-^1A=>W<$^BDGY$<HLZT=V#*+$QI[6%\?IYO[N'27F4R,/1RYH
ML>RJ:DT&[$)UQ/]T<\:]XM81J'XK13RV>QA#@^.7_\R'DWVAS#:J+[D+*A]1
M *,VJ0K+/(E!$I43%C6CL8F="-Y)3%*^5<[F3>554XZ.RK(.6*\B;')QNR^[
MTSL>WX55:W?CE_=L-O*D=E;J'0"&RO2612)/?TIOAITMA4^J/L?4DT5+-_D3
MR8K:MHT8Z;?$.A]F&OFKT=ED<P/R+3DLGY?%Z4?,QT7'+\5I!W=BQ;R<A74$
MG&EDE$&2X1A/@O+I8G5$4&4Z0K@\/*82LAD)W+HKP#DWK7-ZG[(94N<E*803
MT1?)O-J-%I:'E0"_.',)7C"_D7=&=S3W!9Y$30@5-O^RIQIQ$6SI7XU'NOZ(
MU5NOQ.:!U2@4!Y CF<ID6HQ,)6G(DS1N4GRUQ5M['A,9&:I"4$1CNA7//?1O
M<?+B5YDNE,Z4;R,&4NC5[<&8'AI!%UZ:CL^(XI+O<E#"6[YR.[[SBP> + 5-
M!$_/982F^'BNG_CYUH/F _6^@\NI1M#8!^WO1TBCDFIIQ#-.68"7/_U0O/CD
M95@ZAYJ=NC5,\=G$$T?*]HSHT<XW-?1@"3CM0[_!ZC7;D6[.N[)BQ$J7ZV%K
MN):_*H@:C!77U. P?O#!Y^"EIRRQ?,@05$E#/'58SV Z QDW%LR.WC)._^AO
ML&YS'VTH\T_AX)W(XYY1Z1W",<?,PWW_<B&OI%V<?Y%>]K\8FH3>8G&&SSTK
MB9T#19SQX=]@[?HN)!OS5NZ219I[H[E!DO[D?X+GUSM$UD7$(YIC\F-EP\:<
M+E1043E3N99W#>*"\U;B^V\_"RU-61/6N(V,!\57;8N$2ER2K'%DM]$?GR69
MU"__K-W6BV_\\5'\\=[=N.:!C4AUEUP:R(_(9FD<>**"%V%BNU?BU5$(191&
MI8=^5&>:(K1S'FH;YB?Z57M0^E(:\18IY*4X'Z,-2=0U2BU]U3JO#<\Y:2Z>
M=])2O/K4@]#>S+#27]'CC%A%.L?EU^4MX*]U^CP\I@QJ5TE<NJ$';[YKNXFV
M])?)/-M)W")JV^IH.^MD-2P"S=DD;GGZ4AS-3H0@7R.A_G1X$C4!3"]%Y]8]
M,TA%EMG!#+&^=Q7NV/@3K.V]%OV%7C3D.\A7TDBI5-63-04T5B''BH>_C%(]
MX<%R+SN+-&R+WX +#G]?=-_!C:Z,6==".,Y08K(H5!2LQW<-X<V?NP'7W[(!
MZ"3IRN>0+&FW5O,^&G)CA*;LM;:">:$U<;W@O@KF+6[!16>MP#O./0RG'-81
MY<>1&B4AU+>+0BE\BVT2<.DVDLFT%H<+..Q]5V+]0SN0:&UP7E163)<I^RA]
MS*"[M3?T%K""/>I[/W4!FALSKJZ45OTH+G=:MY R4!VHAG?3H![S_E]@^^8!
MH)&&G(1XHOPGNH>Q\JB%6//%BQB7C"K]:WK8?EW8^!EQ9:E8NP>&</A[?H.=
MC^]$HF5L^<N JI(G4?YU#LN+3IB7F,P8E+<TY;?,DM\]B#/.6(9??/!<S&MV
M"M;*@H4QNMWN#67Z)5%1^9MW5^+5TF<:KKY_.[[VVT=QY?V;T;NYEVXD-:W-
M[.A$9(OADQ'A(VOBN3ZZJO)G.^:/>)6+32Q(9R*]:O>J)UXJ/WJXTDM2.*K>
M2)P3Z:PC8B+1]%K5":SGQ!#3,%  <@DL7M*!UYVS'*]]VJ$X:46[M47G+_H5
ML9,<\=DSHI/B,;,1R=\_/K03__; +II4M@V*GA:7FVR:S%.NB;BMCJ4T<@]H
MUTZ;UX ;*-N9B'Q-OGV/#T^B)H 5CHK(NF\:#=)HB7J),5B!U$B;!Q[$K1LO
MP\.[?H?!0@\RV7:;ZK/1%(;7T&,\Y2?$Q1Y("((B]7DC2N4!])6VX*BY%^"%
M1WX"K=EYTGFJ)89S_FLK7B[NK(RK'^C&JS]]!;JVTO#.R9"8I4GRI(RIBOD,
M>Y[E0R%<2%.F[*4F2: ";6(V&*!]<1O^]OR5N/C9*W'H/"KY"!9>Z8C,L4;'
M)C6=QR.>6I!A#EAVFO(L%$(<^Y%?X9$'=@!MC?)D?BQ]TO 6KY3^WEF:RL%2
MM*,';WWE\?A_;SNU)DVUAJR.(?E@_6@$2-,Y)W_T2FS=V(-* V5,91')R=Z0
MZ"[CV*/FXIY_OX@Q&(V*[A!1\9GH,!XMSI312_)\]T 1QW_P"FQ<MQL0B8K+
M7[! T?4XY3\C4*-@C41( S/_=JVRW3F$HXY9@EL^>1Y:<AF*'DN0Q2Y26]O*
M]P:KG2@^05(GJ32Y9%O]RC4/XK+?;\(-=ZWG3<;*9R"O]LG8278TO9I4ATS!
MK;YY\,)>C- T*W6#N>M0HJ+G&)'1J2F(/4!YLW",/_(BZ;!&S^?I)PPT3<@3
MNV"*)1XT-F&!)^UYO(:=J#<]ZU \_X1%#!M-R].?Y4W"I:EA#X\IA*15^NO<
M/V[ M5O8N6QP,I=BIZ-2H4RJ(U2CNZKM.D+<+L/!"EZSH@7?/76QQ8F G9CD
M_ND ^%8P :3,W)"@UDE$E:(Q<1TQJ'47-1^.EQSU"5Q\_#=QTJ*7\?8@!H:W
MF.$*6,EN+" ^%(9_>>AM&"2S*+/G*2+5EEN&!W=<B_^[][WH+6SC/5:V"883
MAE@HG$J4U@-^=.M6O."3UZ)K%],T-T-51T5=EG#QV2FGTJ7\&)B'!3'8:8EI
MZQI )I/!/[[N9-S[F0OPL5>=Z A46'(":4$5"T_,3.A79&4O"KP&-A7 !U58
M1CHWP\3K<B;%LHW$3PG1N1TR/LYY(@.NM)$2(&AOQ/_^^F'\8<U.>Y81$[H;
M>:ASJ#15+GJK2E,X*>;)IM T,B'R62V7/1\BIC)OP@B!4JR$9(<_5G,L?TWM
M.>G3E%::=1J5D0L>0?'JN734,V8Z+ _,M9JKSM7>F#?)![J',&]9,W[^CT]'
M2S[KRDBWZ=7DU IQ?*CN8CFSQ:M1N?WHUHTX^8._P3L_=R-NN.TQ)#3"-:>5
M!"KOY%X$*LV \JYU G1+5?A\-:DD*76**=3HL%(2I=D2IT2I?OA<$2C7H7/Q
M&'1/Y_)+V4C0T#@=5*)X1>&8=XLR1<GAB;U\(EFC3(0M>63F-C-<&=__U1I<
M\,^_PXL_]7O<_FB712O]DZ!>T8)V%Y>'Q]1B:ZF,QXJ4/MHR$7F];5Q1AX@F
M2#; ;:3I4$N@8JCOHO9P:&O6]4/H16U]?T$MP6,\F+*@L9%"HB*R(I/BXB%S
MIZ%Z5VUTX_G"EB/PPJ,_B=><_#]8V?XT# [M1K'<1S\%ZP0[$L0PIL48KQ9O
M\MHX55GF,X7FQOG8T',[OGKGZ[&M9XT]AP'Y-V+9L7&E%/WW[Q[!JS_Y.Q3Z
M^VQ$(566H#!$BDI3;QS9$+[DSSU#864\I3@K_8- L8#7O.!(W/;O%^&2BT_"
MTHXF\V_/T52"R).2S.<IIS(^EF/W?Q+0:)"(@N+3V@R%2R(=#+LIPABQ3"MO
M@G[VT""JL(B83_8HD,TB.53"7WWC#I3%*T5.Y6<2).] PP9&6!XJWY"D-="O
MWCADN4]N,SF2*/FSXM ?%Y\S[*ZGY::#A21E@WXU&A@4(S_1,R1/=K@:T^]L
M@,A!/!+C%C4ZXHWN 32UM.#*#S\?*TD:M+XG[AAI/QF5:U4FQP7K*V)>:F-7
M/[ %YW_BM]8F5]V[$4%+(Y)S6J)'E]C>V88BP=<TO*;MP@I+G/I +W9H6EZ]
M;#9@GBOA#"A]$]6-)<ITB(,M;*^M+_DUW<)SR9)&O!16<9LNB.*Q7Y(FID7>
M99SD)*$HJ?.4H^S,:["I]\NO7XLS/W 5WOR?-V#=]C[Z=0O-W22TA\?400,%
MZX?*V- [1'4FS:1."P78VA!E>P)()YJ>8]@5C6D70C-")L'[!VHV'I. ^O$C
MB[L=S,T4$ _[XP[]'-IZ!EY_XO_@HB,^A+9L)WJ'NTPYV90*>W(B4S*2(E,)
MNALAD$*30J8";<G-LY&L[ZY^-W;TKV6<SA*808R&:O[[JK5XYQ=OH/)CF&:M
M:Z%!304TD*Q6QNN4,._QOD8KI"SMC89!DK]=?3CAJ(7XQ0?/Q[??=39.6-H2
M\1<9#Q%&Y4+"9B;592I2GDZQZ_\DQ4>DS4*.E)<4N"UX5QSZ<5GB39=.PWB]
M!8M(!XEG0*7?D<5]MV_&IWYY'Z-2NIP!&NF9:,1&1H2G/)RK*],#"Y:)$F/9
M<?F)U\%$B1P?M'R:#AH);_^C/S'B>JM1.T;08H)L+E58^2NN"%I[8U!9&C'5
MBQ/.J>Y!]B)BDL@PP6PZ:<I4N5(FB4_AR^\Z#2=KW0^]23ZKT_2VJ'NT;"OK
MT?B>DRF[MNZ*U=]PL8+W??L.//=CU^*W-ZT'&EF'<W)6)RK/LI6\QANCL'13
M/#;J:/J CCKLOUN>7JT<S;-%<FSE+G?5GPX1KNB>I5GG%I>3_^JO'JCH%!?C
M'%5_K%^E15/_3@DH3A=7H$7OG<T\+>,[/WL09WSDM_BO*Q]4JAB=]"'#\$+7
M@<A_="XH=QX>XR(2EEAFA%J=+3NQ;J" "CLV9F\HGQ)E:Z\UXA4/2M1";8^2
M;?%U4(Y/:LW;N>RE.C#["_LO)H\]XN3%K\ ;3[X49RQ['0KE/@P7=E-9N070
MF;#("M!YAKQ)"ID57]&4%P6%A*HQLP!]PUOQW7O?B:W=:TQP1+ $K;5XYY>N
M,\%*-65-[VN@4SW*2EK2I;%.3;E)\*C"-8JFQ:H[BVAJ3N/C?WDV[OC41;CH
MU(4D]4Y81^PF#8_)<?V+A]:PJ+'8Z$MK#O_\W;NQ9DLW[S#M[*6K=Q_#)K-T
MR=;G7.LK?R/*HWY@)$#L@P5F9,\4E5L[-!,@T=8?XP[B!D42ENX"_O(UQ^+B
M<PXQ/X(IUSV4OV59HSVFL7FP85@Y,/O6'HDK[]F"DS]T)?[]VZO(EDI(SF]$
M2B- T9HCMYY1;4R'!7%0<!TL4XU &O@<=:2T!"!EAH%N:O-&C'C*7S7II$:5
M%*?VMC*5H,X5KW5?C5?QT7_21KFBCI?<3"=0OU@':R0]:A=Z7#5-=O"/1J64
M_X8&5!;DL6-K#_[Z"W_$<R[Y'1[8V$]/>@[I)=.C471+7Q1O=;K>PV-O4+N+
M3IVL\YIB5^VP4+;^L*N@N7)>J+-(*R?YIK!J>YY:C&V_N@[4R2 .H\T[MD6=
M&M=^ [:'T;[_='@IGV)(T;:E%^'"E?^(EQW]KVC-+<'NX4T4@#+9=<9^)3*I
MBGNM6D(BIJQ)ATJJC)9<)WJ*F_#M-7^-70-K3;']Y]7K\8[/WXRD9MO:,Y2O
M(H**6YRL4:V$=MFTJ<=(43+.RC!_NLLX^=0%^/W'S\-'7GX<M!6#ADME$*EK
M&9K*TA0MTRVCX9A4G4.I3I&0LK$T9%'N[\>[OWV/%:6V24C+ %@^7+YD&SPF
M#WN+S.8<I=Q$S%66DBF6JPJTSJ&>J&"?BN#_2D\!)YZP#%]X[<GF'I,GD44=
M>X(CZ;PO&=.YVJ<)6!*?^,D#MA[Q@0>V(;&@$6C*\2%JT^1LFFH6P:@IIU$C
M0*8=^$S%92/((A\L:V,S- !IMN%HNM_\B"UIW9+2:^'E7]<R%#QX:=&E]?*
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M $1 F/!RD8D?[L.GWG02CEG2XFY1\N-V6NWT1,HWADUED70;#U&;H2BMVS6
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M!T6R]]Y!//OT0W#IWYZ#Q9T-C LH\[;>T3(#4I,^.Y=PZL04IE9F\5==SRE
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M?FSN+N QDJ\[UO5CU6,[V)?J0Z*?SU=]M3:R2#1*5>#S58=1OD=GW_(F1_N
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MH9A0D;&';&)0T=QNQK8LT&=B&O)M>&CP__#([C^:H(B1::.]6-G-;%!$-:U
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M;%D3$CL&2)Y(&H,\#]>>0C$LY9K16TPJ!QZN#)AWDC%M%APT-0!]!;SAOV[
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MYG7H&71M2R,)TDLN%.O)/<)C%L/Z\:QPV<GKNX;,3FK00&TI*?F)Y&SOT,"
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M-X/&7"<>[;H!NP<V5>.<%: A*[,<U7.QT3>1(Q;/>YYW&,XZ\V $/45>RJU
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M/>QM%I+M"8J7=6*6%=A9PK.>=C!^]Y&GLTRE^S2&[$G43$=<C]861938\=#
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M/L1*[="6PR__L 8_N&FCR8&S'#SA3Y#*DX@QK,[IX$9#//8-D98G1'*L2(T
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M.[<][Z0?G5<;O0I**<QK3N'B@W/F[CJA#K:*>.2RKN&E>!_AE)PJ7 8TNJ9
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MI&A4JP9I']##,CEZ'E9_^@61P^2PFV5YX@>OQ/IU)/0M6N^R%]"0:GL.R^=
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M3RI(4S&J1ZTTEDI]Z&Q8A%RZ3>V$7N4>/YOA]P.L0>I_1#)C2#';U@]C4=N
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M.JPKTUOC(-$UC/83%J/K?UYL?FTAIQG_$5KLC*6[LO*GBSY+M/"=/T;IT=U
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MLA@8[\5H.,#.<)K_^\D'JX.L?^WUBW'IDK=AM#QH=5B=<"+;@('";GSG[K_
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MHC_)VEHDFE.XZL8=N.3]/\&?_?N-V-4WQI>,F02DJ12<<([79\EDLI]P0O2
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MWBSS^$=U;SKT;C_&4^#LN!&Y"7VKQ/9J9L>">2"2(^L27AI-\XZMP-J.[,R
M.#CA(?;-XYA,5(U6Y+<+]+ P098BQ#)=(S'MT!SLKR.H"C=V[S0K,I_L#&)*
MZ>PI;^5PLO..\WMZ'!YU,$!+11QG_MQTG:M3C "CK.X^>A<1ED."\RR^N!M=
MF ^N/C@X8^6(3"-+5>\/!.?O?LH@*JBXCDT(X"GV7%D8.;5_#I-E(7^C.G4
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M^^V[L77?*)!*()<E>4IP<"GMDLE)M]A;!,@1'M/]F"]ZGZ ;R5A!&GR=9:I
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M4%=G?MH[OC'YX/ROUN)Y>'@\/N'71!FBSL5R0B-$W6@]A!..3CZJ"Y",9#=
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MUAZ,#8Z:'60R-D622J5L784M."'4 >CH&:<;4@A\1S.=PV6:(RLU=2Q13ZE
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M7"'NR?<PX0'ET2@2CK:T;P[HFM:$7MF#G-L" 2!?'QPZRU9H(<OM=CN4HGY
MCE?7^,&F7I1RTN6=&;;B?#&KMFVHK.D2'6@V"1DZY32X/(6K#8#"2[*#F4.%
M?1^4;/6&R$:W34%LTD4!_XL,B*4LPHR)9!4/.XN.8DNT7J2(B((<@ J8.:NS
M13&+I725HRA]1:_X1NUB;VA3G#0)T2\U%0E"4(XJ1S^QF.C]1UP?[DWV=*.3
M=(@5X7IOU[JF=2J]DC;NB:9M;?9'*7&D]O!Z%1X88/S]0VN7V_;]JROVPZT-
M^\N+2_;#5YZSMUZZ8%>5'BA[FV8LRA$S3X7(LE]*V1PEXMWI,D&^(=FDL>RJ
MA%D93YNJ2R02B3.1).I91_G"O_/@R-Z[<V __^"._?+CA_;??]BW#^X\LN/]
M@2^!M#H=.^[(^<CS\827SWCI5WD\(<9^+IQX=1L*R_OB1)'TE\'BY/5Q8E#D
MCB$0<H*0*)\L<4<4FX:9"6'#^Q@2HS3RYF\T9)N.ZK0;D;;AK-OE-H582:$[
M/P5((7 FT.^S8LP""=C!C!0ZW%XJ*.E3A.CI*/*/@?*E7ZANIJTIWZBCI)<B
M!2=U0S3BJ;R []^",-2ZY/R=X"A('P,G!0T]3@:4!X%A7%Q8Y=LB? LB73[&
MZD*2CR<CZ5FR$6.*"L6=Z.E_R YC.A)!88F0V;G8""^MLHD9,6R9Z ];^2%W
MG'-VW.*\)NSC24%^"GCUJFS1)C GSHP0V/-W];EEVUKKV.N7ENTG+V_8FUL7
M[*]?7+9>M^OV47!VCR82B<2WCR11SS@8O)/+&/P*G]C]PY;]ZL.[]MO/=NTW
MG^W8?]Q\9!]^_M 6^J(\O*:%I_A4XKC=43&5YUT;.$9]6!YC1@*PY\<?0<.!
M^9-3_/8/9Q8N43)RD#-"$@1J[ Z8^-P>*6ZWX@AG,S'_-RC!1O.SG*C7?V:>
MTB%-^GA<'VQR<P$![&H"T\["M.#I.)M$G8:0#-M/RI(6,U0UG=FY$B;-I[E
MM-UGI;Q,HRT^RZ+Q0,9GRN@*Z5%?,DYL+(=4^D9UZ4:.5R/6(QX6U%&<H<3^
M*S]W:5'WEY_+)=G.Q!8'JD_W$F=N!:$+PD9_^WY Z7=[V(/&355FF:AI?>."
MW;C:L;>V-NU'6RNZ]NSZYJIM\%0J8E+!Q5':U&S?K%\2B43BVT&2J&<=&CV6
M=>0^2X*@M!ICQ@EGMG,TL$^V']E'.R/[V>^W[9<?[]BG.WV[_:AO@_V^M8[D
M[" :K)2P!"@'Z4M5P:T$'+;3)_E'7H C9UL<NB^?$69F0@CG5AU\D"AR2)UW
M\L2;SI <\OEX7DU3 )+@1$IQGY$2JKZF#E#KJ#JP%6=?Y2GOYV]5(%_:,\4W
M0J0>M[TI[UW:L,/-)*&6*42*I^[0TYR1 LQ>D>ZS4 "[D"U*6:Z#/-$<[B,G
M0JA4&=YSQU)7W=\GNJW"L<^.,1T?:VS9/*__7&?5S2PF!Z9R;A=GD'<6K;V\
M:%L;*_;&I:X_/?>#%U?LM<T5^]ZEU;)5;+8$IY$AP>-8'2U*)!*)[QZ21#WS
MD*/S(9P1!'=J3I["_;C#K*.,K-(/=+F]<V"?[QS9+T2H_O.6"-:=1_;^=M^7
M!JU_),?9=>?F2SZ<SR,G.V&?E<+LRZ$N/W) 3K;N0W)'R&Q#\<:>K?I]TW=8
M(.#829?CA!H5NY\$'+<O&KGJ( YGE6CJ0C>],%T&+([:20 VD%F!S(D$(;C&
MZ9B7;4(-]W:5*&U^$NB/DY@E0&! 4]>QCVE)H7 A4[0.(D7=P/NBV.DSAVV-
M@]*X)WPV2AVZR-23,#;>$BFTQ*3'RE.Q(7*ML2_G+2WP$EY($[8LV("G3Y7>
M\KU,,;OE=B\OV0OK';OQ_*I][W+7WKRV:6]=[=CW19IX%R+C6-O"_8'MV,:3
MB)%82)03MI!LMJ>&$XE$XMM&DJAG'!PJZ4_XR;EQU+EHCIQ4#*GO56%X?9]*
M$!9%/*^(A,.BA.3PM;S%_];VGOWN]B/[Z?OW[8L' _N?>_MV>W=D!WL'MC"0
MN^-T=:8/6'91&5YU0EE?+E. &2-F$]@?XP[/'TF70RQL@+U2D)BI"3C]$IY'
ME:E SE^O(N<ZGW<J:!=7"%0MT%J<UN_79N7T5S/A220*G"A\$LXKA:CV;+G
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9EX;9_P(S%60.K8X./@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140391546680688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  08,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEOGENOMICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001077183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">74-2897368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9490 NeoGenomics Way,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort Myers,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(239)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">768-0600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock ($0.001 par value)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NEO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>neo-20230508_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="neo-20230508.xsd" xlink:type="simple"/>
    <context id="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001077183</identifier>
        </entity>
        <period>
            <startDate>2023-05-08</startDate>
            <endDate>2023-05-08</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM180L2ZyYWc6NDI0MTdiZjY3MzA4NDZjZGI4Zjk3ZjRjZTQ5NGY3ZTcvdGFibGU6OThkNDMwOGQ2ZWFiNDQxNjhiNTg5MzE1MzBjYmYzMjAvdGFibGVyYW5nZTo5OGQ0MzA4ZDZlYWI0NDE2OGI1ODkzMTUzMGNiZjMyMF8xLTEtMS0xLTE2NzU0OA_dcb5e5b1-b63c-4857-b7df-189640d21fae">0001077183</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM180L2ZyYWc6NDI0MTdiZjY3MzA4NDZjZGI4Zjk3ZjRjZTQ5NGY3ZTcvdGFibGU6OThkNDMwOGQ2ZWFiNDQxNjhiNTg5MzE1MzBjYmYzMjAvdGFibGVyYW5nZTo5OGQ0MzA4ZDZlYWI0NDE2OGI1ODkzMTUzMGNiZjMyMF8yLTEtMS0xLTE2NzU0OA_73c3e4e3-36cb-4ff4-b94f-dc0b209aa477">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV84Mw_f48bbb60-1364-4a8e-a2bb-4e9e321e60d0">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yMjQ_b02090ba-16ff-432a-8a85-dd74fa47086d">2023-05-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yMjk_d088e705-865e-4760-a37c-0465a69ae00a">NEOGENOMICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6NGU3OThkNDM4MDNkNDdjNjllZDFmZDM3NDAwNmNlNWMvdGFibGVyYW5nZTo0ZTc5OGQ0MzgwM2Q0N2M2OWVkMWZkMzc0MDA2Y2U1Y18wLTAtMS0xLTE2NzU0OC90ZXh0cmVnaW9uOmIxYjYyYzc3MzVkNDRjNmM5YjRiZGY5MjYzMTNhOWZjXzQ_de1971ac-bcbd-4a85-bec6-da7525658369">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6NGU3OThkNDM4MDNkNDdjNjllZDFmZDM3NDAwNmNlNWMvdGFibGVyYW5nZTo0ZTc5OGQ0MzgwM2Q0N2M2OWVkMWZkMzc0MDA2Y2U1Y18wLTItMS0xLTE2NzU0OC90ZXh0cmVnaW9uOjE4ODZmMTExZjI2ODQ5OTQ5ZjZkYzBiNWU1ZDVmMGExXzQ_e98075e7-268d-44ea-a2f0-56f65e4fba1e">001-35756</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6NGU3OThkNDM4MDNkNDdjNjllZDFmZDM3NDAwNmNlNWMvdGFibGVyYW5nZTo0ZTc5OGQ0MzgwM2Q0N2M2OWVkMWZkMzc0MDA2Y2U1Y18wLTQtMS0xLTE2NzU0OC90ZXh0cmVnaW9uOjcxMTE2NGZiYTkxNTRhZTM4ZDRhZmY3NWRkYTFiZTA5XzQ_07a96693-e8df-49c1-a09e-61b2ff66eccd">74-2897368</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6MGZmYTM2NDFhZGU0NDhjZDhiMDQ5YjY2MDA0MWVlZGMvdGFibGVyYW5nZTowZmZhMzY0MWFkZTQ0OGNkOGIwNDliNjYwMDQxZWVkY18wLTAtMS0xLTE2NzU0OA_57638ca6-94be-468c-8558-dd250b822136">9490 NeoGenomics Way,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6MGZmYTM2NDFhZGU0NDhjZDhiMDQ5YjY2MDA0MWVlZGMvdGFibGVyYW5nZTowZmZhMzY0MWFkZTQ0OGNkOGIwNDliNjYwMDQxZWVkY18wLTEtMS0xLTE2NzU0OA_2a2df5ff-8e87-468c-82f4-8e025ace3445">Fort Myers,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6MGZmYTM2NDFhZGU0NDhjZDhiMDQ5YjY2MDA0MWVlZGMvdGFibGVyYW5nZTowZmZhMzY0MWFkZTQ0OGNkOGIwNDliNjYwMDQxZWVkY18wLTItMS0xLTE2NzU0OA_ae9142ea-de61-420f-951d-89a983225c51">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6MGZmYTM2NDFhZGU0NDhjZDhiMDQ5YjY2MDA0MWVlZGMvdGFibGVyYW5nZTowZmZhMzY0MWFkZTQ0OGNkOGIwNDliNjYwMDQxZWVkY18wLTMtMS0xLTE2NzU0OA_bb8bc631-0293-4ead-89f4-5f919e289de2">33912</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yOTQ_ed45af1b-671e-4c23-b420-3134dd22a7bb">(239)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yOTc_1af9b3e0-30d6-473a-aa2d-01ba10452bf0">768-0600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6OGNhNjRhOTNiYWUwNGRmODhjNDFiOTRkZjk3NWNhM2EvdGFibGVyYW5nZTo4Y2E2NGE5M2JhZTA0ZGY4OGM0MWI5NGRmOTc1Y2EzYV8wLTAtMS0xLTE2NzU0OA_3f57f4e0-5753-4c7f-9149-a37109f388b9">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6OGNhNjRhOTNiYWUwNGRmODhjNDFiOTRkZjk3NWNhM2EvdGFibGVyYW5nZTo4Y2E2NGE5M2JhZTA0ZGY4OGM0MWI5NGRmOTc1Y2EzYV8xLTAtMS0xLTE2NzU0OA_2d569a16-0ecf-4591-ada3-40f6dc09f5aa">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6OGNhNjRhOTNiYWUwNGRmODhjNDFiOTRkZjk3NWNhM2EvdGFibGVyYW5nZTo4Y2E2NGE5M2JhZTA0ZGY4OGM0MWI5NGRmOTc1Y2EzYV8yLTAtMS0xLTE2NzU0OA_55874bb4-b1a6-4c49-bd48-5c23151e7d5a">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6OGNhNjRhOTNiYWUwNGRmODhjNDFiOTRkZjk3NWNhM2EvdGFibGVyYW5nZTo4Y2E2NGE5M2JhZTA0ZGY4OGM0MWI5NGRmOTc1Y2EzYV8zLTAtMS0xLTE2NzU0OA_894789f9-2214-445c-acd0-2160c0324812">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6ODRmOGFlNTYxNmZhNDBmM2FiNTUxZWY5Yzk2OWIxZTYvdGFibGVyYW5nZTo4NGY4YWU1NjE2ZmE0MGYzYWI1NTFlZjljOTY5YjFlNl8xLTAtMS0xLTE2NzU0OA_5335b153-b55d-4f81-a8d7-50b4622b0edb">Common stock ($0.001 par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6ODRmOGFlNTYxNmZhNDBmM2FiNTUxZWY5Yzk2OWIxZTYvdGFibGVyYW5nZTo4NGY4YWU1NjE2ZmE0MGYzYWI1NTFlZjljOTY5YjFlNl8xLTItMS0xLTE2NzU0OA_3af8f1c9-ab53-4059-81e1-e60ff4de6d44">NEO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6ODRmOGFlNTYxNmZhNDBmM2FiNTUxZWY5Yzk2OWIxZTYvdGFibGVyYW5nZTo4NGY4YWU1NjE2ZmE0MGYzYWI1NTFlZjljOTY5YjFlNl8xLTQtMS0xLTE2NzU0OA_d147130e-f328-4228-b3cb-f61f284539ed">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8yMDcx_4fe82490-f56d-4c16-86ca-f953030e14dc">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentPeriodEndDate
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGV4dHJlZ2lvbjpmNGI1ODc5MDMxZjQ0ZmZhOTNlYzY3MzAyOGQzODc5ZV8xMDk5NTExNjI5ODY1_b02090ba-16ff-432a-8a85-dd74fa47086d">2023-05-08</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjYjUyNDgyYTEzZTQyZTY5OTJmMDg0ZTVhNzM5ZjAzL3NlYzo4Y2I1MjQ4MmExM2U0MmU2OTkyZjA4NGU1YTczOWYwM18xL2ZyYWc6ZjRiNTg3OTAzMWY0NGZmYTkzZWM2NzMwMjhkMzg3OWUvdGFibGU6NjcxZjkzMzRhYWQwNDI1NGEwMDVhOGQ0ZTIwZDM1ZGUvdGFibGVyYW5nZTo2NzFmOTMzNGFhZDA0MjU0YTAwNWE4ZDRlMjBkMzVkZV8yLTEtMS0xLTE3Nzk3MQ_b02090ba-16ff-432a-8a85-dd74fa47086d">2023-05-08</dei:DocumentPeriodEndDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M/UY_ 5!+ 0(4 Q0    ( %*!J%8'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 4H&H5AU==@CN
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ 4H&H5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " !2@:A6^WR?.$H$  !U$   &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ 4H&H5I^@&_"Q @  X@P   T              ( !C0P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " !2@:A6EXJ[',     3 @  "P
M    @ %I#P  7W)E;',O+G)E;'-02P$"% ,4    " !2@:A6JL0B%C,!   B
M @  #P              @ %2$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ 4H&H5B0>FZ*M    ^ $  !H              ( !LA$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 4H&H5F60>9(9 0  SP,
M !,              ( !EQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  X1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="neo-20230508.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://neogenomics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="neo-20230508.htm">neo-20230508.htm</File>
    <File>a99-103312023earningsrelea.htm</File>
    <File>neo-20230508.xsd</File>
    <File>neo-20230508_lab.xml</File>
    <File>neo-20230508_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "neo-20230508.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "neo-20230508.htm"
     ]
    },
    "labelLink": {
     "local": [
      "neo-20230508_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "neo-20230508_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "neo-20230508.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "neo",
   "nsuri": "http://neogenomics.com/20230508",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "neo-20230508.htm",
      "contextRef": "ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://neogenomics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "neo-20230508.htm",
      "contextRef": "ia4e4377a459a4e319fb798f2ecc31827_D20230508-20230508",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://neogenomics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001077183-23-000039-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001077183-23-000039-xbrl.zip
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MT/W-PP=T%H[)'-SC J*G O++CWU5E2].,X5T7%YY$]#&L\*QH!2*A0]2H7R
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MI<A  ?"J#=C#\+(WI=?H: X0S<<C&&JQ_H?X!7R#@>W88>S[VH,HY,/AE7$
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M[,]Z>56L! M+:QL2G]'C"CM.UG5>AEHEJ4HC,,?$BAQ6C.^5#$Q:MYN5Y%G
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MPCABN]_;UW)9YGK'MOPUA:=99BZ'?QC"EK#4YS4Q"=N(B5&R6M2^7@?AMU1
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ML?N;74U2^B?ME%WX-F8%R:0I7:FO[F@UBCW)O84-@:O[B9EW-&Q&;1+WI-6
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MDR[RVF&7\F./&MM9@E!9(&X<YM0\_%6#*I+400B10\VG]+WN'(<UZG=6[D#
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M"L<X1*]>Y%AH0%;X$@><Q>E4;)=FZO-#]E% [Z:P]X0 K-:<65_7-SC<:#(
ME< 8=CG,O7T*]I"-M,'?,+9/EJ)9MAMZ\T'Y<N*:S0.+U*:+VPZ"B" +Q #B
MAY'B!Q9SLO L0$$$I%F='9_8&(" V1%W=7YNK!>G]% Z7.!DEE#DAK:S)&M8
M'Z0Q"5:[U;.6PO!D*\&S6+?S=;L4Y*O*PMU)2:TOW%C5B(5;Q,+=OOY6%IRV
MV<5<>ZN-^6^_#JC3NV7HF/$TN<U6]L9RB7LT,]]^^;VX/[:\> 4/P%\'FV3K
M*Z?O/+ZQO!25E5+S/A/7F]@F. NWKME&Z)<?%56_0,C0#1DMW4=_X=GB+GA%
M(;J;$1_>^_0%:9JAJ&M[ 4L_Q_Z"?"/2&@#7?VOA(<!]CIU78)M5[$Q P,;3
M[.@ 1P8L,N(?'(G*NTBDS;H1>J2+\RA2<F,*&U%8-H68+(J21H.MJT=O;_:1
MCR]N-F,^>7@G'5+TE8#4,FW'GF=DW,?19?0)!!7< F'U.;(M^)50A_G*\T$*
M33TN<-B#=TSJPJ0RBID\B#H]7IBB/./N801C6+ F07N1:;BHNX3P!)S),/A0
M(X@C%T?@-!)K.U!KUMJF<590D')NN[#J6$ Z&O="K[;C4 7.'4I0L8,9,D$_
MTPA1?"@W"1T!55C2$3JSY\&E]2@1WEJA"2R3@-#XT)D-K[LK-0+09HT ]AP\
MZ*<=$V;6RIG]\B$.-'D :PBXFH>\VNB9&=S)\PM#8.[9 WRK&,$OV'9H:)K"
MPJ8U]AP+M W[VNJSR[7%C LT]E[)"XV(P6QF2Q_SR<1[@6\-?6^R:A3R+RZ;
MBDE$8?,;F1V#TK :(!\-/<?Q7IG1R9#JQS*4F8X$)"0PG#MC^Z6]BX S(UAI
MCN=]8R&4%2S1%/68P\P5T9KL\H$9&XO7Y72Y13O:^:6;O]T^7U]*Z;C?2*M;
M1W@JACE\<\.,[:$ IAT\#<AY\LM%<@3+=AF^V$L7,0%C:R[%*6(?Y+<7)DE;
MYF9)O,T;?SF^W6:WUK9\^+UNO]W1U:VWY;:R]=Y;PRI:N]???ONM8=^^IQF=
MXTQ6RS3L.UOI[VX_&AN/'BKM*$U3EDM1_I-@']VP'8MK8A+FKB5[+2GY._NB
M>FFW.,<>9HK%6:8TAR\># /:<WN=G)Q@-PM]O\/O*?AK0GKYO%IY>A*Q. S3
MD,,PBM*5X!/E.P\C3G4)1L[%R'*_G(Q\R',JBE9R_CMT^>7J'H#0.I0=Q3$5
M0:43G%*IAG!XM^IGPZI]JKT=F$^<US@UE;K%4JE1]H,H^?G#;[M(!6$X-(M(
M]2\E5V5#YR%]R[%AYHTBK!M!)'$6-5<S[B8?3#S3<X:BQ:'3ZM!6,\I)VT;9
M);=T!Q8\+)[*C;\WSB0Y4[2=-@F$/7(Z"G4*HU"C(BW79.H3T]X][EI=WUT3
M$98J4&F7N&OYMF9*(@3><4UXSNLQ:CPW.HFB4AD4JGK8!(HR64V"?6O/OLJ!
M\W^.6-59Z115UGD)6C!0D>5%]&#""KA%5WS..\4FZ.G[Y1,_*X5%=LS?;8!4
MJY+LDMN&4N6@A&"WBK%;7Z]\A*4$-=O9B.=V"%\SLR3'+M5V";W58YPK0GWW
MPOT'U,-E[]Y0C3#;H1.BJQO9E=MJ3V0#"!J)^'NV9.C]TH:J&_<%'LS;1U?$
MYD]/H^I'YJLA)PZ7$5UEM21WA.D@:-3D?.@JVSJ'S(>NLM*4A6$C:%2BE(-M
MQ8,4M;"F95^7BLLOE3#?*+Z^K<YZ!5N6*4HS^Y7ML-:$5=<H&IWZ= A;?47L
M[VZT*[MY?#J1)$N;T,Z23#U.4?:,6$Q+7UL1J#N?-JCU!F8^X,LMK\[DMM8]
MW"F3,EG>@GF;P+P'/")5G@2V [:"/U@5RW)-L@GG8/]B?RSU#<%!$$W2.V3%
MM<=%(D1M]C&N5SWX]+3%FGM3BMH7-1$$F<KH]Y8M#OC 6UM)&XVM>%W^18NH
M6)ZX7KC2N*'Z44%UGZA@=2/PK-V#>B$V2@292K574HJP8(JEO&<MF56/)>XR
MLG[N9H_00ODX=R_M?@@\5<AX$VQ1?K9@@O C:Q;TVYO]GZB'N&+>%=08-F.'
MJ'^M_]NI^:VBK3>]2063/W9H2(_< E<1W>'G#:X/U,R]3@W<-]9[G=?"D78>
M,ZZ%3XP?1"/W]7[0)6T$7:K6[7NH9-$X6C2.KG7CZ%0:'*KM^@F]>:8EGJ+I
MU"%4/H"XNG7!AIBL5E^K-'17<(GJYJ+2EO8Q'K2BTI9B2QIT=8 >B4]9@G#%
M^I6\$#<B]>"-+#VQ=P;HM+UU#:.MR+U=6NMVU+;6R=96-L^P8*T;RFY-<-^^
MU^GLUK"W7I/MG:0/L-+)T@BXA!U4G\<^(>@.GAL'<3/?.^R#B:TI4IZ>JGER
M++)&TTJ.NI4^Q_N VRR<J0)G^7#V,[H:%][BN+#,^J+-TGTR  HS2^,=WN7<
MN_04A.8F;%9BDI4[%2U.6N];568>[0R94SE-G,J&G;56^QU)[W5%%E')R=3M
M2K*6MVZ$(-.)R=1K:X60J A8?\YC)Y=/VQ6@0<LW88&$LMA253ZQ<AEO9_L\
M%/_+CWKO@EI5HM9VE8L?Z[):^?,W@N.JQ'%:3Y0Y*;F!VV_KA9!(&+BE>%(@
M02!!)--OP-BH9/HC;;9D3"!.MJGBL"WYSK)ZX[]XRCAS0ECF^>,8^Q.,GHC_
M8IMO)8-O$BI3XNAJXDUKC;-7,HFJ-I#(B3U63NS'@6?-X#_C<.+\]O\!4$L#
M!!0    ( %.!J%;UN/$*Z14  '^8   0    ;F5O+3(P,C,P-3 X+FAT;>U=
M;7?:NK+^?GZ%+^?><]*U(I#\;MKFK#00#GO7IB&D;/RE2[;E8#"8;9OP\NOO
MR(:$!)+0- ED[W2M)A"]C:29T3.CD?3I/]-!*%RQ. FBX><"*>*"\)^C3_^#
MT!]?FE^%2N2.!VR8"B<QHRGSA$F0=H6VQY*^X,?10&A'<3^XH@AE94ZBT2P.
M+KNI(&)1NI,8ESW)9[JD&,B071G)#!.DJX:")-=W=8U)FN*YAY=E;$B:H?@$
M:517D>Q+"G(DE2&FZIKO2KJL>.JA5]9=1Q%E7:1$8K+(5,,0?:S+3*&:9/A8
MXLUV4^@=]'"8E*=.' :?"]TT'95+I<ED4N1_*4;Q94G$6"H%PR2E0Y<5%OD]
M=I,[RYDPMW@9794@ 4J(Y$]YF368I@A2;U6^S!T,PV#(^&"6TI@.$S^*!S2%
MP88ZB(*PCB2RK =R]A^@D"<[-+FF<+J6?R)EN8EA&*4L]8;"^^HET@J)US4G
MP:9Z@0I2^L/\>NYVV8"B.R-V/R5\%E;&:C,I#PV4B!$6$1&S2LHA'5Y^+K A
MNC@OP!0SZAU]&K"4"KQ:Q/X<!U>?"R?1, 7&1:W9" AT\V^?"RF;IJ6,GM+1
M/_[QCT]ID(;L:,@BQ#D6*UC_5,K_]JF4U^Q$WNSHDQ=<"4DZ"]GG@A<DHY#.
MRL-HR*#]8%KF&5F<?PP\CPVSCY!N@?#$@9LW/TV;S/]<"*C,9$G3J*P8\%$B
MAN]HANZ+S'4EHHO:C\J2E&N:"L*0#GC3+"A7AT#?[ 1Z$].P/O38]'<V*PB!
M!U5[TO>94XFNOHK-JXYDCKU>]<JN&;U&K]OK]"YF5N5RUFE5YW;K;&:W.DJC
M]=O K%QBN_6]:\U-Q>X=S[]*5MB91W)'K!.S=R:;@^K4%"^P.;@0&ZW^#/+(
M5NV"=%KNO-'N3$RBXZ^B/>NT7=6JU+'9\@*[!ZW/(5_%[MFUNFSW^I+=:_:@
M7<6J=22[Y5YYM=/ J5VHC5:W;U7,2:-V)MKMT\"JG$VM7C>P6I>*.:\2<_ZE
MUQETYF;O>%'F.[2E#.U6I$ 9S-NQ*W;8:=>Q5:F*C5J=-"K]N=FZF)LU"V@Q
M9^:I/OW:JJ;F.>:_16M^@1O'/SS0($QQ"')4R46RKFC(T3P?$=U09>R)Q*<P
MPQBX'FL:T:5/I5O3^I*S? Q:U^.:]S2DEP4A%P:H=IJ6_6#*/.33D&N"]VE_
M>-IG&Z9=DUQ8,9B$)-5U8'WQ9>08LH\\%SLB-BB5-:UP='K\];RZ-N.EVS(>
M,Y_%#'1@LD$S<05<3C)="3PA9 JYG((^^EQ(@L$HY(HS^ULWYBRSJH2*T\2#
M&DJWJ\B;OVES04(2C>/L6[;$E1=LF+/&4]AP61'+-,WR6^#Q[W[ 8B$CB&U<
M[D[JO]^6F+N%CY9_NEW["(8W\I;?8%V)TPH CB-.%,)\G5R6NTF[)M.[)^LR
M9?E]V4CIUD M1_5Z&$LK*KT$BC_7_MEP/H8Y?I#":IG%BC$(AJC+."XJR\HH
M_3@)O+1;)AC_7R'+=_0I&5%@*"<N0>G\<U[)6E4<9R @.J9N6D[&@P&-9Q_A
MQR4TD4:CL@S5\TXA&@:7P[(+H\SB0M[ L@XW"J.X_$^<_?OHPRB -AD$X:S\
M[U8P %:VV$1H1@,Z_/=A BLQM!D'?IXQ">:L3#1H)?LZR7NE03U\]5[VDHB\
M:Q=6O56M".>MXU;U_':_5GJT+]2>5T\NFO56O7HN'%L5H?K'R7^/K5I5.&F8
M9OW\O-ZP=M@%<:LNM&G2#8:7:30\%"HG@,$5V5@2_;+TR!OI^=<_B8H_;C]L
M.><&0ZXLRJ(,C3S[0.+G('Q%WK*1V!<6/FTT3>$%0<G2&LPQ]2ZAQW0)/0!>
M<,@@-5K'<[/=P5;-'G1:_;G=-F&Y-R=FK]LWYY#>O@ 8\5WV_OM;:(OAE=,;
M#:P,,KB*63&G=N\,VP.[VVAQ6C(8,P.8,>?I]G==-B<_?%EW'$?%B$@J6*]4
M9XB*#@ (9C!))$S%'BX<Z>CW=="P+R+X+DM;ZU)8#)I5JR4TJ]\:S=;>J_YO
MXS@9TV$JI)%PSEQN-^<#3R0AB@6B''@?A+WO1>0+:9?Q#HSC( V@XNK4[0*H
M9L*QFPJ03 Q)?G.\Q$$H)[[)1E&<"@?+[XP"#&5)*K K[F.+LV3F?=C[>7J%
M->9;AM6K.8*_;0![\!<T@#:[O!CRZ S-8"@1&_Z]%J49T/7#P6"R8H<BHOH^
MDB61(IWJ"O(\3?;!DL6Z"I:D26>Y.M /,]?L?4O4.T9[,MFBM&O1R3V#3789
M)-R#FEJ0\K>3B/X/#^LZT[""=%5A2-8 L5%)<Q&6586J!F48T\*156W4JE;#
MK)^<'PIUZZ3X=)%X<0'8S$D'U2F%19'//U],XNMY%V@B)"/F<G^+)P1#(4@3
M 9916%OB#_L#1A\266DGJ_<V5*?4"=F2!">*/18CH"2DHX25EQ\^+O<(\DT-
ME!5:NFF<*$VC09D[@JY8G 8N#1?=S'J<)R]\1)I>U#'A:B.-X;^W;'CA02IF
M&J64>NMI,BYB7;LW&1?)O6D/52L61<EX]EH)*6KX_J+[1:RD0[7R5M66LEG+
M9PYX@W/0YX)46!884<\+AI=E<305R&V.#YF_SA[1J+!OF@B_RII6'[I1#. X
MVP\\3P'_G43C81K/3B+O-CCD_E'N(D[9*(ZN>#UO%!7FNR10E[38*9'-B@6_
MO9[5"T.[<CJP*Z9D58XGUL *K;9Y=Y<$Z'87.R67$U,\PY9HBHWV][[9MJ$=
M%YN58[$C JU$GWQM'=_>)3DQL/U'%[N#[T/:-L:-07W:Z75FG;D+:^YWH*/9
MLP:FTH$^V;6.8O8Z<[-E=1MMN_?'_.R'QXBA$>HBQW4\[BM1D,-<%;"ZIHB*
MJNB2:L :S*ZH1Q]>>)<R]H#X8"X\A:VRODO:(Y)V&H0,:G>@A^]2\[C4U!^6
MFEY5;E3L@=FJ G*MBXW*&8S/&8R)W>_,OP16^X+8E>\#LU:=<JEAAHXUA6E(
M5'60&IE11$4?(T7U <K*OD-)MA]-D*1HBOHN.'LD."TZK2\V.=ULF7J7HJVE
MZ.P1*7*G)D^KV0'0/+5:S:[=,F6[ K\''<EJ-_N=UFE@MXX5+D58HX:J&A)B
MNN<CV7 )HMA@2"6.Z/NJ"M/J%8XT&8FZH4FJOH48/2^.RQ'^*\N)OI68'&3@
MBGN,H[3+8J$WCH/$"S)_\NX,XNUH!QLX6,6)'_9 '^[S5)]$@T&0)&]@9CDH
M$7)]^CZI#T]JO=@LGA>%ZF 41C,6[_O,WEXR!2LJ;IK@3/V6,B?*7FR*[)^?
M2%:+AF@\R4\D%G51>7[7"RY*QO-72Z2BKDC/7ZU>5,3MG&5/AP*+_9.-B/E9
M^=78#T1\['DQ2Y+%KZ]  'G#:-C,\D!ZY;1KURZP5>GV[$HW,,&FZ_0Z(B!:
M;+:_AW9M#0U/^(Z%.>] ^FD?^H0;-:O?J-4G5B4,K![05CF;VH".-WIBCG\H
MFBKI+E61(3L,R:KN(EU1=.1YHH(=712)I!:.#-G P!I1C0VC0> F0IO.#N]B
M6T&X"0)XTGKX-V7B$_C8B&$JW[(S\?58>"WD6J2BYRN^CW2F:PL6%GT9OF)1
MH2Z39%D!G,>C(TR +<D:X[YS[1.X-C/F&O&W.+H*LG,Z?UU'^>OQ=OTN;U-F
M$%ED%'E,)4@6L8\,A7A(-ZBA2Z*HN H!W@;."AYP=K_S]?9\_2T"Q@WM8)1O
M_[PS[:-,:]YE6L?1'5>5",*B(2&94<ZOH) 5WR &$W7#8V+A2)(,(C[(LAOA
ML+%7O+NEY;S@+1Y*,8I!708C&@ILRMQQ&ESQ" NP4EGRX8T([):=!AD2N!!]
M6)_4>^WMUX^RW"X>Y@6U#X=_QS&C;U;?/#VBJM$Z^\$\6:$^<9"J$3! 7%%"
M#JQS2"*2#$:(2#7' 682)>/#FL'Q@K/R-0(1^M:-AF]YQ_)79L;]0:AO.!*#
MJ<">BF1-HH@"U$:8.)1@61$='Q>.-%5'6,5X?T+<'E5/>83;32SCO_ZIBT3[
MF @I"]F(S[DPS";]D#O]PS%7N (%$04.6U%GN_<#_F4C:G=$Y$F7N?WLE  =
M@>4"2S7?L'*BJ>"P,)H(07Z$ $S)@:"CWP4_"#EK! GP2<I@D#U^1"()!N,P
MI4,6C9-P)B0T#1)_EI5<%(@<F*+<*[TXE; 28#F&>F*!#F?+-#\*H7%>CEM3
M =]4282#A#&AQH8L!B11'T+9<;:1)AP7Q6).[H?RVG _\["J>^^[-HRBAK7[
M?-</N73%(I'5YX_O*VJ2_J1:'VY149X_%E$WBH;R"XYK]9<#/5Y="[RTI=F.
M@Q04!=\='0\7&U/)NNO$B:+0H2#U*>B>-XD\%O<PU*RNU6MRE!%TVA<3J]8<
M-, .!9LT:+2:?7Z'@]6VNJ98O6N# HT\*J.JF.)O7;MUC.U:1V[43+!)ZTI6
M3\LED&?>^;[1KRWYBN;+ %X430$;U-5\9!#9X-'Z!!N^I.N.P563H<GRQY\,
M=GHR8Z]N[NZ&MQ<,"'U9Y4!AM'+"KSD&_2R+RF(ANG-FCA^5.R":<'+:%("_
MBY#QWEW5=X7PJ$(XC\+ A9$=7IH -0!OA._:X!>UP72#-A ]134H41%FKH]@
MK@BB'@6]@'W5<T$?*)3^#;7!#?<)@P7[K:L"(E-$Q!5M<.O8[+4ND $/9#G?
MU<'3U<&WF'%LP"_@R>Y"X#9%W/!][G]X5PN_I!9FFS:_%5V3'4=&#J$J@ 3
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M;0(  &X'   0    ;F5O+3(P,C,P-3 X+GAS9,U56V^;,!1^SZ_P>)ZYA)
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M?>VVF^4=KE;WO;=^5M#M]6SP"E!+ P04    " !3@:A66-CI>H$*  !Q80
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MSST+ZZ#HCV8!\JR_ZK%KVMKZ-F.I%\H:3]+H$R(- Y):STC@J=6)%#Y5\O&
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MB54:',"TD#RR/PR1V1=!1TN[8T"ZZ'=<@[W+OL$9Q[DEPDOTVWD4149!3&3
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M)[J7[E\81WM_ E!+ 0(4 Q0    ( %.!J%;Q@(9M/D8  )NC!  >
M      "  0    !A.3DM,3 S,S$R,#(S96%R;FEN9W-R96QE82YH=&U02P$"
M% ,4    " !3@:A6];CQ"ND5  !_F   $               @ %Z1@  ;F5O
M+3(P,C,P-3 X+FAT;5!+ 0(4 Q0    ( %.!J%9Q",+5;0(  &X'   0
M          "  9%<  !N96\M,C R,S U,#@N>'-D4$L! A0#%     @ 4X&H
M5EC8Z7J!"@  <6$  !0              ( !+%\  &YE;RTR,#(S,#4P.%]L
M86(N>&UL4$L! A0#%     @ 4X&H5@'_/0G3!@  4S,  !0
M ( !WVD  &YE;RTR,#(S,#4P.%]P<F4N>&UL4$L%!@     %  4 3 $  .1P
$      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
